<title>Wilms Tumor and Other Childhood Kidney Tumors Treatment (PDQ&reg;): Treatment - Health Professional Information [NCI]-General Information</title>
<div id="mainContent_ctr"> 
 <div id="middleContent_fmt"> 
  <div id="ContentPane5">
   <div class="pop_toolst_rdr" id="lln-toolsres"> 
    <script type="text/javascript">
		//Removes Popular Tools from TOC pages or where www.webmd.com is followed by "news-features"
		if (window.s_topic.substring(0,1) != "7" && window.s_publication_source != "WebMD Image Collection" && (window.s_business_reference != "TOC" || window.s_channel_health == "Health Insurance and Medicare") && window.s_business_reference != "TOC - Mini-Center Topic" && window.s_business_reference != "TOC - Guide" && window.s_business_reference != "TOC - Guide" && window.s_business_reference != "Nav - A-Z page" && window.s_business_reference != "Glossary"){
			$('.pop_toolst_rdr').css('display','block');
			webmd.oas = window.webmd.oas || {}; webmd.oas.mapping = window.webmd.oas.mapping || {}; webmd.oas.mapping['oas_tools_and_resources'] = ['x56','x57','x58','x59','x60','x61'];
		}
		</script> 
    <div class="pop_toolst_top_fmt">
     <h2>Tools &amp; Resources</h2>
     <ul>
      <li id="x56"><a href="http://www.webmd.com/cancer/video/men-bladder-cancer" class="type_vid" onclick="return sl(this,'','lln-toolsres_1');">Bladder Cancer in Men<i> </i></a></li>
      <li id="x57"><a href="http://www.webmd.com/cancer/health-check-cancer-risk/default.htm" onclick="return sl(this,'','lln-toolsres_2');">Assess Your Cancer Risk</a></li>
      <div class="breaker_fmt"></div>
      <li id="x58"><a href="http://www.webmd.com/breast-cancer/slideshow-breast-cancer-overview" class="type_ss" onclick="return sl(this,'','lln-toolsres_3');">Breast Cancer: A Visual Overview<i> </i></a></li>
      <li id="x59"><a href="http://www.webmd.com/cancer/video/humor-therapy-cancer" class="type_vid" onclick="return sl(this,'','lln-toolsres_4');">Humor Therapy for Cancer<i> </i></a></li>
      <div class="breaker_fmt"></div>
      <li id="x60"><a href="http://www.webmd.com/cancer/pancreatic-cancer/slideshow-pancreatic-cancer-overview" class="type_ss" onclick="return sl(this,'','lln-toolsres_5');">Understanding Pancreatic Cancer<i> </i></a></li>
      <li id="x61"><a href="http://www.webmd.com/lung-cancer/slideshow-lung-cancer-overview" class="type_ss" onclick="return sl(this,'','lln-toolsres_6');">Lung Cancer: The Big Picture<i> </i></a></li>
      <div class="breaker_fmt"></div>
     </ul>
     <div class="breaker"></div>
    </div>
    <script class="oas_template" id="oas_tools_and_resources" type="text/html"><a class="{type_prefix}{type}" onclick="return sl(this,'','lln-toolsres_{link_position}');" href="{href}">{alt}{i_tag}</a></script>
    <div class="pop_toolst_bot_fmt"></div>
   </div> 
   <script type="text/javascript">
if (window.$) { 
	$(document).ready(function() {
		// produce array from value(s) of 'secTopId'
		var mySplitResultsecTopId = secTopId.split("|");
		var wloop = mySplitResultsecTopId.length;
		
		//Hides the Pop Tools list on pages with a sensitive secondary topic id. 
		for (i = 0; i < wloop; i++) {
			if (mySplitResultsecTopId[i].substring(0,1) == 7){
				$('.pop_toolst_rdr').css('display','none');
			}
		}
		//Hides the Pop Tools list on Actionset Pages
		if ($('.actionset').length) {
			$('.pop_toolst_rdr').css('display','none');
		}
	});
}
</script> 
   <!--
    Updated at 03/2/12 at 12:00pm VDT
<webmd_rendition><content><wbmd_asset object_type="wbmd_cons_article" id="091e9c5e80e9969c" xmlns:xalan="http://xml.apache.org/xalan"><metadata_section><i_chronicle_id>091e9c5e800f4449</i_chronicle_id><r_object_id>091e9c5e80e9969c</r_object_id><title>General Information</title><object_name>ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml</object_name><content_template>consumer_import_health_ref.xml</content_template><r_object_id>091e9c5e80e9969c</r_object_id><wbmd_archive_bool>0</wbmd_archive_bool><wbmd_bus_ref object_type="wbmd_lookup" wbmd_lookup_type="business_reference" wbmd_storage_val="16" wbmd_disp_nm="Medical Reference"></wbmd_bus_ref><wbmd_cpyrt><r_object_type>wbmd_copyright</r_object_type><r_object_id>091e9c5e8015ba98</r_object_id><wbmd_legal_revw_dt>nulldate</wbmd_legal_revw_dt><wbmd_copyright_strt_dt>nulldate</wbmd_copyright_strt_dt><wbmd_copyright_end_dt>nulldate</wbmd_copyright_end_dt><wbmd_copyright_holder><r_object_type>wbmd_company</r_object_type><r_object_id>091e9c5e80041b32</r_object_id><wbmd_bus_comp_nm>Healthwise</wbmd_bus_comp_nm><wbmd_comp_type object_type="wbmd_lookup" wbmd_lookup_type="company_type" wbmd_storage_val="5" wbmd_disp_nm="Third Party Vendor"></wbmd_comp_type><wbmd_bus_logo chronic_id="091e9c5e80019c57" directive="imageurl" object_type="wbmd_cons_img" path=""></wbmd_bus_logo></wbmd_copyright_holder><wbmd_legal_revr></wbmd_legal_revr><wbmd_copyright><wbmd_copyright_statement>Some material in CancerNet™ is from copyrighted publications of the respective copyright claimants. Users of CancerNet™ are referred to the publication data appearing in the bibliographic citations, as well as to the copyright notices appearing in the original publication, all of which are hereby incorporated by reference. </wbmd_copyright_statement></wbmd_copyright></wbmd_cpyrt><wbmd_ext_id>nci_ncicdr0000062789-general-information</wbmd_ext_id><wbmd_med_ref_type></wbmd_med_ref_type><wbmd_wdw_ttl>Wilms Tumor and Other Childhood Kidney Tumors Treatment (PDQ®): Treatment - Health Professional Information [NCI]-General Information</wbmd_wdw_ttl><wbmd_site_archv_ovrd_dt>nulldate</wbmd_site_archv_ovrd_dt><wbmd_prim_revw_dt>nulldate</wbmd_prim_revw_dt><wbmd_publ><r_object_type>wbmd_publication</r_object_type><r_object_id>091e9c5e80378509</r_object_id><publ_i_chronicle_id>091e9c5e8001915b</publ_i_chronicle_id><wbmd_publ_name>Healthwise - NCI</wbmd_publ_name><wbmd_publ_display>WebMD Public Information from the National Cancer Institute</wbmd_publ_display><wbmd_publ_bus_entity><r_object_type>wbmd_company</r_object_type><r_object_id>091e9c5e80041b32</r_object_id><wbmd_bus_comp_nm>Healthwise</wbmd_bus_comp_nm><wbmd_comp_type object_type="wbmd_lookup" wbmd_lookup_type="company_type" wbmd_storage_val="5" wbmd_disp_nm="Third Party Vendor"></wbmd_comp_type><wbmd_bus_logo chronic_id="091e9c5e80019c57" directive="imageurl" object_type="wbmd_cons_img" path=""></wbmd_bus_logo></wbmd_publ_bus_entity></wbmd_publ><wbmd_prim_subj_cd></wbmd_prim_subj_cd><wbmd_desc_meta>This cancer treatment information summary provides an overview of the prognosis,diagnosis,classification,staging,and treatment of Wilms’ tumor and other childhood kidney tumors (clear cell sarcoma of the kidney,rhabdoid tumor of the kidney,neuroepithelial tumor of the kidney,and cystic partially-differentiated nephroblastoma,and renal cell carcinoma).  The National Cancer Institute ...</wbmd_desc_meta><wbmd_orig_pub_dt>02/25/2014 00:00:00</wbmd_orig_pub_dt><wbmd_desc_user>This cancer treatment information summary provides an overview of the prognosis,diagnosis,classification,staging,and treatment of Wilms’ tumor and other childhood kidney tumors (clear cell sarcoma of the kidney,rhabdoid tumor of the kidney,neuroepithelial tumor of the kidney,and cystic partially-differentiated nephroblastoma,and renal cell carcinoma).  The National Cancer Institute ...</wbmd_desc_user><wbmd_lk_ttl>Wilms Tumor and Other Childhood Kidney Tumors Treatment (PDQ®): Treatment - Health Professional Information [NCI]-General Information</wbmd_lk_ttl><wbmd_disclmr><r_object_type>wbmd_disclaimer</r_object_type><r_object_id>091e9c5e800cc78f</r_object_id><wbmd_lgl_revw_dt>nulldate</wbmd_lgl_revw_dt><wbmd_lgl_revr></wbmd_lgl_revr><wbmd_disclaimer><disclaimer_statement><p>This information is not intended to replace the advice of a doctor.
Healthwise disclaims any liability for the decisions you make based on this
information.</p></disclaimer_statement></wbmd_disclaimer></wbmd_disclmr><wbmd_prim_med_revr></wbmd_prim_med_revr><wbmd_keywords>Wilms’ Tumor and Other Childhood Kidney Tumors</wbmd_keywords><wbmd_relv1_subj_cd_group><wbmd_relv1_subj_cd></wbmd_relv1_subj_cd></wbmd_relv1_subj_cd_group><wbmd_authr_prim_group><wbmd_authr_prim></wbmd_authr_prim></wbmd_authr_prim_group><wbmd_relv2_subj_cd_group><wbmd_relv2_subj_cd></wbmd_relv2_subj_cd></wbmd_relv2_subj_cd_group><wbmd_relv3_subj_cd_group><wbmd_relv3_subj_cd>Age.1</wbmd_relv3_subj_cd></wbmd_relv3_subj_cd_group><r_object_id>091e9c5e80e9969c</r_object_id><wbmd_c_cons_edtr></wbmd_c_cons_edtr><wbmd_c_cons_cpy_edtr></wbmd_c_cons_cpy_edtr><wbmd_c_cons_revw_dt>nulldate</wbmd_c_cons_revw_dt><wbmd_c_sec_med_revw_dt>nulldate</wbmd_c_sec_med_revw_dt><wbmd_c_sec_med_revr></wbmd_c_sec_med_revr><wbmd_c_prim_top_id object_type="wbmd_lookup" wbmd_lookup_type="consumer_topic_id" wbmd_storage_val="2729" wbmd_disp_nm="Kidney Cancer"></wbmd_c_prim_top_id><wbmd_c_edtr_revr_dt>nulldate</wbmd_c_edtr_revr_dt><wbmd_c_stg_of_cond></wbmd_c_stg_of_cond><wbmd_c_sec_authr_group><wbmd_c_sec_authr></wbmd_c_sec_authr></wbmd_c_sec_authr_group><wbmd_c_audnc_age_group><wbmd_c_audnc_age></wbmd_c_audnc_age></wbmd_c_audnc_age_group><wbmd_c_audnc_geo_group><wbmd_c_audnc_geo></wbmd_c_audnc_geo></wbmd_c_audnc_geo_group><wbmd_c_sec_top_id_group><wbmd_c_sec_top_id></wbmd_c_sec_top_id></wbmd_c_sec_top_id_group><wbmd_c_audnc_gndr_group><wbmd_c_audnc_gndr></wbmd_c_audnc_gndr></wbmd_c_audnc_gndr_group><wbmd_c_audnc_lfstyl_group><wbmd_c_audnc_lfstyl></wbmd_c_audnc_lfstyl></wbmd_c_audnc_lfstyl_group><wbmd_c_audnc_read_lvl_group><wbmd_c_audnc_read_lvl></wbmd_c_audnc_read_lvl></wbmd_c_audnc_read_lvl_group><wbmd_c_audnc_ethn_group><wbmd_c_audnc_ethn></wbmd_c_audnc_ethn></wbmd_c_audnc_ethn_group><wbmd_c_tm_of_yr_group><wbmd_c_tm_of_yr></wbmd_c_tm_of_yr></wbmd_c_tm_of_yr_group><wbmd_c_clncl_tgt_pop_group><wbmd_c_clncl_tgt_pop></wbmd_c_clncl_tgt_pop></wbmd_c_clncl_tgt_pop_group><wbmd_c_art_thmbnl></wbmd_c_art_thmbnl><wbmd_c_channel_id object_type="wbmd_lookup" wbmd_lookup_type="consumer_channel_id" wbmd_storage_val="1068" wbmd_disp_nm="Kidney Cancer"></wbmd_c_channel_id><wbmd_c_frnd_nm>Wilms-tumor-Treatment-Health-Professional-Information-NCI-PDQ-General-Information</wbmd_c_frnd_nm><wbmd_c_asset_name></wbmd_c_asset_name><wbmd_c_teaser></wbmd_c_teaser><wbmd_c_mini_article object_type="wbmd_cons_shrt_txt" directive="expand" chronic_id="0000000000000000"></wbmd_c_mini_article></metadata_section><content_section><cons_import_health_ref><title>General Information</title><pages><page><section_group><section_header></section_header><section_type>Vendor</section_type><section_text><p>Fortunately, <a chronic_id="" crossLinkId="31192" directive="friendlyurl" externalId="9A13E96B1FF14D08" href="http://www.webmd.com/cancer/" keywordId="7043" keywordSetId="942" object_type="" path="/webmdhttp://www.webmd.com/cancer/">cancer</a> in children and adolescents is rare, although the overall incidence of childhood cancer has been slowly increasing since 1975.[<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">1</a>] Children and adolescents with cancer should be referred to medical centers that have a multidisciplinary team of cancer specialists with experience treating the cancers that occur during childhood and adolescence. This multidisciplinary team approach incorporates the skills of the primary care physician, pediatric surgical subspecialists, <a chronic_id="091e9c5e804d6f9a" crossLinkId="1049001" directive="friendlyurl" externalId="091e9c5e804d6f9a" href="/webmd/consumer_assets/editorial/articles/health_and_medical_reference/cancer/miscellaneous/what_to_expect_from_radiation_therapy.xml" keywordId="61840" keywordSetId="27679" object_type="wbmd_cons_article" path="/webmd/consumer_assets/editorial/articles/health_and_medical_reference/cancer/miscellaneous/what_to_expect_from_radiation_therapy.xml">radiation</a> oncologists, pediatric medical oncologists/hematologists, rehabilitation specialists, pediatric nurse specialists, social workers, and others in order to ensure that children receive treatment, supportive care, and rehabilitation that will achieve optimal survival and quality of life. (Refer to the PDQ Supportive and Palliative Care summaries for specific information about supportive care for children and adolescents with cancer.) </p><p>Guidelines for pediatric cancer centers and their role in the treatment of pediatric patients with cancer have been outlined by the American Academy of Pediatrics.[<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">2</a>] At these pediatric cancer centers, clinical trials are available for most of the types of cancer that occur in children and adolescents, and the opportunity to participate in these trials is offered to most patients/families. Clinical trials for children and adolescents with cancer are generally designed to compare potentially better therapy with therapy that is currently accepted as standard. Most of the progress made in identifying curative therapies for childhood cancers has been achieved through clinical trials. Information about ongoing clinical trials is available from the NCI Web site. </p><p>Dramatic improvements in survival have been achieved for children and adolescents with cancer.[<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">1</a>] Between 1975 and 2006, childhood cancer mortality has decreased by more than 50%. Childhood and adolescent cancer survivors require close follow-up since cancer therapy side effects may persist or develop months or years after treatment. (Refer to the PDQ summary on Late Effects of Treatment for Childhood Cancer for specific information about the incidence, type, and monitoring of late effects in childhood and adolescent cancer survivors.)</p><p><b>Prognosis</b></p><p>Wilms tumor is a curable disease in the majority of affected children. Approximately 500 cases are diagnosed in the United States each year. Since the 1980s, the 5-year survival rate for Wilms tumor has been consistently above 90%.[<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">1</a>] This favorable outcome occurred despite reductions in the length of therapy, dose of radiation, extent of fields irradiated, and the percentage of patients receiving <a chronic_id="" crossLinkId="1049001" directive="friendlyurl" externalId="091e9c5e804d6f9a" href="http://www.webmd.com/cancer/what-to-expect-from-radiation-therapy" keywordId="72076" keywordSetId="32532" object_type="" path="/webmdhttp://www.webmd.com/cancer/what-to-expect-from-radiation-therapy">radiation therapy</a>.[<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">3</a>] The prognosis for patients with Wilms tumor is related not only to the stage of disease at diagnosis, the histopathologic features of the tumor, patient age, and tumor size, but also to the team approach provided to each patient by the pediatric surgeon, radiation oncologist, and pediatric oncologist (COG-AREN9404).[<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">4</a>,<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">5</a>,<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">6</a>,<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">7</a>] Patients who develop Wilms tumor in their second decade of life have a poorer survival (5-year survival, 63%) than younger patients with Wilms tumor.[<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">8</a>]</p></section_text></section_group></page><page><section_group><section_header is_continued="true"> continued...</section_header><section_type>Vendor</section_type><section_text><p>In an analysis of Wilms tumor patients in the Surveillance, Epidemiology and End Results database, adults (n = 152) had a statistically worse overall survival (OS) (69% vs. 88%, <i>P</i> &lt; .001) than pediatric patients (n = 2,190), despite previous studies showing comparable outcome when treated on protocol.[<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">9</a>,<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">10</a>] Adults with Wilms tumor were more likely than pediatric patients to be staged as having localized disease, to not receive any lymph node sampling, and to not receive any radiation treatment. The investigators recommended that all adult patients diagnosed with Wilms tumor should undergo lymph node sampling and that there should be close collaboration with pediatric surgeons and oncologists in treatment planning. The Children's Oncology Group has increased the enrollment age for their Wilms tumor trials to include patients up to age 30 years.[<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">11</a>]</p><p><b>Congenital Anomalies and Syndromes Predisposing to Wilms Tumor</b></p><p>Wilms tumor typically develops in otherwise healthy children; however, approximately 10% of children with Wilms tumor have a congenital anomaly.[<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">12</a>] Children with Wilms tumor may have associated urinary tract anomalies, including hemihypertrophy, cryptorchidism, and hypospadias. Children may have a recognizable phenotypic syndrome (including overgrowth disease, aniridia, genetic malformations, and others). These syndromes have provided clues to the genetic basis of the disease. The phenotypic syndromes have been divided into overgrowth and nonovergrowth categories. </p><ul type="disc"><li><b>Overgrowth syndromes.</b> Overgrowth syndromes are the result of excessive prenatal and postnatal somatic growth.[<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">13</a>,<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">14</a>] Examples of overgrowth syndromes include the following:<ul type="circle"><li>Beckwith-Wiedemann syndrome (prevalence is about 1% of children with Wilms tumor).[<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">15</a>,<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">16</a>,<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">17</a>,<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">18</a>]</li><li>Isolated hemihypertrophy (prevalence is about 2.5% of children with Wilms tumor).[<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">15</a>,<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">19</a>]</li><li>Perlman syndrome (characterized by fetal gigantism, renal dysplasia, Wilms tumor, islet cell hypertrophy, multiple congenital anomalies, and <a chronic_id="091e9c5e8070f589" crossLinkId="1585033" directive="friendlyurl" externalId="091e9c5e8070f589" href="/webmd/consumer_assets/editorial/articles/health_and_medical_reference/childrens_health/miscellaneous/intellectual_disability_mental_retardation.xml" keywordId="66466" keywordSetId="30421" object_type="wbmd_cons_article" path="/webmd/consumer_assets/editorial/articles/health_and_medical_reference/childrens_health/miscellaneous/intellectual_disability_mental_retardation.xml">mental retardation</a>).[<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">20</a>] Germline inactivating mutations in DIS3L2 on chromosome 2q37 are associated with Perlman syndrome.[<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">21</a>]</li><li>Sotos syndrome (characterized by cerebral gigantism).</li><li>Simpson-Golabi-Behemel syndrome (characterized by macroglossia, macrosomia, renal and skeletal abnormalities, and increased risk of embryonal cancers).</li></ul></li><li><b>Nonovergrowth syndromes.</b> Examples of nonovergrowth syndromes associated with Wilms tumor include the following:<ul type="circle"><li>WAGR syndrome (aniridia, genitourinary anomaly, and mental retardation). The constellation of WAGR syndrome occurs in association with an interstitial deletion on chromosome 11 (del[11p13]).[<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">22</a>,<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">23</a>] (prevalence is about 0.4% of children with Wilms tumor). The incidence of bilateral Wilms tumor in children with WAGR syndrome is about 15%.[<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">24</a>]</li><li>Isolated aniridia.</li><li>Genitourinary anomalies including hypospadias, undescended testis, and others are associated with Wilms tumor 1 (WT1) mutations (prevalence is over 6% of children with Wilms tumor). Children with pseudo-<a chronic_id="091e9c5e8001ef67" crossLinkId="32736" directive="friendlyurl" externalId="091e9c5e8001ef67" href="/webmd/consumer_assets/controlled_content/healthwise/nord/ovotesticular_disorder_of_sex_development_nord_nord772.xml" keywordId="36148" keywordSetId="8946" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nord/ovotesticular_disorder_of_sex_development_nord_nord772.xml">hermaphroditism</a> and/or renal disease (glomerulonephritis or <a chronic_id="091e9c5e8001e1cd" crossLinkId="43395" directive="friendlyurl" externalId="091e9c5e8001e1cd" href="/webmd/consumer_assets/controlled_content/healthwise/major/Nephrotic_Syndrome-Topic_Overview.xml" keywordId="70984" keywordSetId="32066" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/major/Nephrotic_Syndrome-Topic_Overview.xml">nephrotic syndrome</a>) who develop Wilms tumor may have the Denys-Drash or Frasier syndrome (characterized by male hermaphroditism, primary amenorrhea, chronic <a chronic_id="091e9c5e807f0f5b" crossLinkId="44346" directive="friendlyurl" externalId="091e9c5e807f0f5b" href="/webmd/consumer_assets/controlled_content/healthwise/special/acute_kidney_injury-topic_overview_special_aa115364.xml" keywordId="36970" keywordSetId="1420" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/special/acute_kidney_injury-topic_overview_special_aa115364.xml">renal failure</a>, and other abnormalities),[<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">25</a>] both of which are associated with mutations in the WT1 gene.[<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">26</a>] Specifically, germline missense mutations in the WT1 gene are responsible for most Wilms tumors that occur as part of the Denys-Drash syndrome.[<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">27</a>,<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">28</a>]</li><li>Bloom syndrome.</li><li>Alagille syndrome.[<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">29</a>]</li><li><a chronic_id="091e9c5e809b2719" crossLinkId="1550666" directive="friendlyurl" externalId="091e9c5e809b2719" href="/webmd/consumer_assets/editorial/articles/health_and_medical_reference/childrens_health/what_is_trisomy_18.xml" keywordId="70705" keywordSetId="10013" object_type="wbmd_cons_article" path="/webmd/consumer_assets/editorial/articles/health_and_medical_reference/childrens_health/what_is_trisomy_18.xml">Trisomy 18</a>.</li><li>Li-Fraumeni syndrome (familial cancer syndrome).</li></ul></li></ul></section_text></section_group></page><page><section_group><section_header is_continued="true"> continued...</section_header><section_type>Vendor</section_type><section_text><p><b>Screening Children Predisposed to Wilms Tumor</b></p><p>Children with a significantly increased predisposition to develop Wilms tumor (e.g., most children with Beckwith-Wiedemann syndrome, WAGR syndrome, Denys-Drash syndrome, idiopathic hemihypertrophy, or sporadic aniridia) should be screened with <a chronic_id="091e9c5e80743115" crossLinkId="1523137" directive="friendlyurl" externalId="091e9c5e80743115" href="/webmd/consumer_assets/editorial/articles/health_and_medical_reference/healthy_living/miscellaneous/What_Is_an_Ultrasound.xml" keywordId="41424" keywordSetId="10032" object_type="wbmd_cons_article" path="/webmd/consumer_assets/editorial/articles/health_and_medical_reference/healthy_living/miscellaneous/What_Is_an_Ultrasound.xml">ultrasound</a> every 3 months at least until they reach age 8 years.[<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">13</a>,<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">14</a>,<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">15</a>,<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">30</a>]</p><p>Approximately 10% of patients with Beckwith-Wiedemann syndrome will develop a malignancy, with either Wilms tumor or hepatoblastoma being the most common, although adrenal tumors can also occur.[<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">31</a>] Children with hemihypertrophy are also at risk for developing <a chronic_id="091e9c5e80348a30" crossLinkId="73851" directive="friendlyurl" externalId="091e9c5e80348a30" href="/webmd/consumer_assets/editorial/articles/image_collections/anatomy_pages/liver_2.xml" keywordId="42791" keywordSetId="10464" object_type="wbmd_cons_article" path="/webmd/consumer_assets/editorial/articles/image_collections/anatomy_pages/liver_2.xml">liver</a> and adrenal tumors. Screening with <a chronic_id="091e9c5e8001f09d" crossLinkId="50786" directive="friendlyurl" externalId="091e9c5e8001f09d" href="/webmd/consumer_assets/controlled_content/healthwise/medicaltest/abdominal_ultrasound_medicaltest_hw1430.xml" keywordId="6740" keywordSetId="736" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/medicaltest/abdominal_ultrasound_medicaltest_hw1430.xml">abdominal ultrasound</a> and serum alpha-fetoprotein is suggested until age 4 years; after age 4, most hepatoblastomas will have occurred, and imaging may be limited to renal ultrasound, which is quicker and does not require the child to fast for the exam.[<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">32</a>]</p><p>Children with Klippel-Trénaunay syndrome, a unilateral limb overgrowth syndrome, had been considered to be at increased risk for developing Wilms tumor. The risk of Wilms tumor in children with Klippel-Trénaunay syndrome, when assessed using the National Wilms Tumor Study (NWTS) database, was no different than in the general population and routine ultrasound surveillance is not recommended.[<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">33</a>]</p><p><b>Genetics of Wilms Tumor</b></p><p>Wilms tumor (hereditary or sporadic) appears to result from changes in one or more of at least ten genes. Several, but not all, will be discussed here. </p><p><b>Wilms tumor 1gene (WT1)</b></p><p>The WT1 gene is located on the short arm of chromosome 11 (11p13). The normal function of WT1 is required for normal genitourinary development and is important for differentiation of the renal blastema. Germline mutations in WT1 have been found in about 2% of phenotypically normal children with Wilms tumor.[<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">34</a>] Germline WT1 mutations in children with Wilms tumor does not confer a poor prognosis <i>per se</i>. The offspring of those with germline mutation in WT1 may also be at increased risk of developing Wilms tumor. Because deletion of WT1 was the first mutation found to be associated with Wilms tumor, WT1 was assumed to be a conventional tumor suppressor gene. However, non-inactivating mutations can result in altered WT1 protein function that also results in Wilms tumor, such as in the Denys-Drash syndrome.</p><p>WT1 mutation is more common in those children with Wilms tumor and one of the following:</p><ul type="disc"><li>WAGR syndrome, Denys-Drash syndrome, or sporadic aniridia.</li><li>Genitourinary anomalies, including hypospadias and cryptorchidism.</li><li>Bilateral Wilms tumor.</li><li>Unilateral Wilms tumor with nephrogenic rests in the contralateral <a chronic_id="091e9c5e803f72c0" crossLinkId="72677" directive="friendlyurl" externalId="091e9c5e803f72c0" href="/webmd/consumer_assets/editorial/articles/image_collections/anatomy_pages/picture_of_the_kidneys.xml" keywordId="60461" keywordSetId="26662" object_type="wbmd_cons_article" path="/webmd/consumer_assets/editorial/articles/image_collections/anatomy_pages/picture_of_the_kidneys.xml">kidney</a>.</li><li>Stromal and rhabdomyomatous differentiation.[<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">25</a>]</li></ul><p><b>WT1mutation, aniridia, and genitourinary malformation</b></p><p>The observation that lead to the discovery of WT1 was that children with WAGR syndrome (aniridia, genitourinary anomalies, and mental retardation) were at high risk (&gt;30%) for developing Wilms tumor. Germline mutations were then identified at chromosome 11p13 in children with WAGR syndrome. Deletions involved a set of contiguous genes that included WT1 and the PAX6 gene (responsible for aniridia). Aniridia is characterized by hypoplasia of the iris and it occurs in sporadic or familial cases and has an autosomal dominant inheritance. Mutations in the PAX6 gene lead to aniridia. The PAX6 gene is located on chromosome 13 closely associated with the WT1 gene, deletion of which confers the increased risk of Wilms tumor. Some of the sporadic cases of aniridia are caused by large chromosomal deletions that also include the Wilms tumor gene – WT1. This results in an increased relative risk of 67-fold (95% confidence interval [CI], 8.1–241) of developing Wilms tumor in children with sporadic aniridia.[<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">35</a>] Patients with sporadic aniridia and a normal WT1 gene, however, are not at increased risk for developing Wilms tumor. Children with familial aniridia generally have a normal WT1 gene and are not at an increased risk of Wilms tumor. The mental retardation in WAGR syndrome may be secondary to deletion of other genes including SLC1A2 or BDNF (<a chronic_id="091e9c5e8041fa4e" crossLinkId="73853" directive="friendlyurl" externalId="091e9c5e8041fa4e" href="/webmd/consumer_assets/editorial/articles/image_collections/anatomy_pages/picture_of_the_brain.xml" keywordId="60487" keywordSetId="26677" object_type="wbmd_cons_article" path="/webmd/consumer_assets/editorial/articles/image_collections/anatomy_pages/picture_of_the_brain.xml">brain</a>-derived neurotrophic factor).[<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">36</a>]</p></section_text></section_group></page><page><section_group><section_header is_continued="true"> continued...</section_header><section_type>Vendor</section_type><section_text><p>The incidence of Wilms tumor in children with sporadic aniridia is estimated to be about 5%.[<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">24</a>] Patients with sporadic aniridia should be screened with ultrasound every 3 months until they reach age 8 years, unless genetic testing confirms that they are negative for WT1.[<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">15</a>,<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">30</a>]</p><p><b>Monitoring for late renal failure</b></p><p>Children with WAGR syndrome or other germline WT1 mutations are at increased risk of eventually developing <a chronic_id="091e9c5e800232f5" crossLinkId="536" directive="friendlyurl" externalId="091e9c5e800232f5" href="/webmd/PageBuilder_Assets/scopemaps/WebMD Consumer/Pages/Hypertension Health Center/page_Hypertension Health Center_091e9c5e800232f5.xml" keywordId="7630" keywordSetId="1371" object_type="wbmd_pb_page" path="/webmd/PageBuilder_Assets/scopemaps/WebMD Consumer/Pages/Hypertension Health Center/page_Hypertension Health Center_091e9c5e800232f5.xml">hypertension</a>, nephropathy, and renal failure and should be monitored throughout their lives.[<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">37</a>] Patients with Wilms tumor and aniridia without genitourinary abnormalities are at lesser risk but should be monitored for nephropathy or renal failure.[<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">38</a>] Children with Wilms tumor and any genitourinary anomalies are also at increased risk for late renal failure and should be monitored. Features associated with germline WT1 mutations that increase the risk for developing renal failure are stromal predominant histology, bilaterality, intralobular nephrogenic rests, and Wilms tumor diagnosed before age 2 years.[<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">37</a>]</p><p><b>WT1interactions</b></p><p>Activating mutations of the beta-catenin gene (CTNNB1) have been reported to occur in 15% of Wilms tumor patients. In one study, all but one tumor with a beta-catenin mutation had a WT1 mutation and at least 50% of the tumors with WT1 mutations had a beta-catenin mutation.[<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">39</a>,<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">40</a>] That CTNNB1 mutations are rarely found in the absence of a WT1 or WTX mutation suggests that activation of beta-catenin in the presence of intact WT1 protein must be inadequate to promote tumor development.[<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">41</a>,<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">42</a>]</p><p>WT1 mutations and 11p15 loss of heterozygosity are associated with relapse in patients with very low-risk Wilms tumor who do not receive <a chronic_id="091e9c5e80d59ba7" crossLinkId="1577663" directive="friendlyurl" externalId="091e9c5e80d59ba7" href="/webmd/consumer_assets/editorial/articles/health_and_medical_reference/cancer/miscellaneous/chemotherapy_what_expect.xml" keywordId="74390" keywordSetId="33709" object_type="wbmd_cons_article" path="/webmd/consumer_assets/editorial/articles/health_and_medical_reference/cancer/miscellaneous/chemotherapy_what_expect.xml">chemotherapy</a>.[<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">43</a>] These may provide biomarkers to stratify patients in the future.</p><p><b>Wilms tumor 2gene (WT2)</b></p><p>A second Wilms tumor locus, WT2 gene, maps to an imprinted region of chromosome 11p15.5, which, when constitutional, causes the Beckwith-Wiedemann syndrome. About 3% of children with Wilms tumors have constitutional epigenetic or genetic changes at the 11p15.5 growth regulatory locus without any clinical manifestations of overgrowth. These children may be more likely to have bilateral Wilms tumor or familial Wilms tumor.[<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">36</a>] There are several candidate genes at the WT2 locus, comprising the two independent imprinted domains IGF2/H19 and KIP2/LIT1.[<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">44</a>] Loss of heterozygosity, which exclusively affects the maternal chromosome, has the effect of upregulating paternally active genes and silencing maternally inactive ones. A loss or switch of the imprint for genes (change in methylation status) in this region has also been frequently observed and results in the same functional aberrations. A study of 35 sporadic primary Wilms tumors suggests that more than 80% have somatic loss of heterozygosity or loss of imprinting at 11p15.5.[<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">45</a>] The mechanism resulting in loss of imprinting can be either genetic mutation or epigenetic change of methylation.[<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">36</a>,<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">44</a>] Loss of imprinting or gene methylation are rarely found at other loci, supporting the specificity of loss of imprinting at IGF2.[<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">46</a>] Interestingly, Wilms tumors in Asian children are not associated with either nephrogenic rests or IGF2 loss of imprinting.[<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">47</a>]</p></section_text></section_group></page><page><section_group><section_header is_continued="true"> continued...</section_header><section_type>Vendor</section_type><section_text><p>Beckwith-Wiedemann syndrome results from constitutional loss of imprinting or heterozygosity of WT2. Observations suggest genetic heterogeneity in the etiology of Beckwith-Wiedemann syndrome with differing levels of association with risk of tumor formation.[<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">48</a>] Molecularly defined subsets of Beckwith-Wiedemann patients may not require ultrasound screening for malignancies. Approximately one-fifth of patients with Beckwith-Wiedemann syndrome who develop Wilms tumor present with bilateral disease, though metachronous bilateral disease is also observed.[<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">15</a>,<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">16</a>,<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">17</a>] The prevalence of Beckwith-Wiedemann syndrome is about 1% among children with Wilms tumor reported to the NWTS.[<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">17</a>,<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">49</a>,<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">50</a>]</p><p><b>Wilms tumor gene on the X chromosome(WTX)</b></p><p>A third gene, WTX, has been identified on the X chromosome and plays a role in normal kidney development. WTX mutations were identified in 17% of Wilms tumors, equally distributed between males and females.[<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">51</a>] This gene is inactivated in approximately one-third of Wilms tumors but germline mutations have not been observed in patients with Wilms tumor.[<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">52</a>]</p><p><b>Other genes</b></p><p>Additional genes have been implicated in the pathogenesis and biology of Wilms tumor:</p><ul type="disc"><li><b>16q and 1p:</b> Additional tumor-suppressor or tumor-progressive genes may lie on chromosomes 16q and 1p as evidenced by loss of heterozygosity for these regions in 17% and 11% of Wilms tumors, respectively. Patients classified by tumor-specific loss of these loci had significantly worse relapse-free and OS rates. Combined loss of 1p and 16q are used to select favorable-histology Wilms tumor patients for more aggressive therapy in the current Children's Oncology Group study.[<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">53</a>]</li><li><b>CACNA1E:</b> Overexpression and amplification of the gene CACNA1E located at 1q25.3, which encodes the ion-conducting alpha-1 subunit of R-type voltage-dependent <a chronic_id="" crossLinkId="137422" directive="friendlyurl" externalId="781" href="http://www.webmd.com/vitamins-supplements/ingredientmono-781-calcium.aspx?activeingredientid=781&amp;activeingredientname=calcium" keywordId="63581" keywordSetId="28846" object_type="" path="/webmdhttp://www.webmd.com/vitamins-supplements/ingredientmono-781-calcium.aspx?activeingredientid=781&amp;activeingredientname=calcium">calcium</a> channels, may be associated with relapse in favorable-histology Wilms tumor.[<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">54</a>]</li><li><b>7p21:</b> A consensus region of loss of heterozygosity has been identified within 7p21 containing ten known genes, including two candidate suppressor genes (Mesenchyme homeobox 2 [MEOX2] and Sclerostin domain containing 1 [SOSTDC1]).[<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">55</a>]</li><li><b>SKCG-1:</b> Genomic loss of a growth regulatory gene, SKCG-1, located at 11q23.2, was found in 38% of examined sporadic Wilms tumors and particularly the highly proliferative Wilms tumors. Additional studies of si-RNA silencing of the SKCG-1 gene in human embryonic kidney epithelial cells resulted in a 40% increase in cell growth, which suggests that this gene may be involved in loss of growth regulation and Wilms tumorigenesis.[<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">56</a>]</li><li><b>p53</b> tumor suppressor gene: A small subset of anaplastic Wilms tumors show mutations in the p53 tumor suppressor gene. Although it is unlikely that it plays a major role in Wilms tumorigenesis, it may be useful as an unfavorable prognostic marker.[<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">57</a>,<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">58</a>]</li><li><b>FBXW7:</b> FBXW7, a ubiquitin ligase component, has been identified as a novel Wilms tumor gene. Mutations of this gene have been associated with epithelial-type tumor histology.[<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">59</a>]</li><li><b>MYCN:</b> Genomic gain or amplification of MYCN is relatively common in Wilms tumors and associated with diffuse anaplastic histology.[<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">59</a>]</li></ul></section_text></section_group></page><page><section_group><section_header is_continued="true"> continued...</section_header><section_type>Vendor</section_type><section_text><p><b>Genetics of Familial Wilms Tumor</b></p><p>Despite the number of genes that appear to be involved in the development of Wilms tumor, hereditary Wilms tumor is uncommon, with approximately 2% of patients having a positive family history for Wilms tumor. Siblings of children with Wilms tumor have a low likelihood of developing Wilms tumor.[<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">60</a>] The risk of Wilms tumor among offspring of persons who have had unilateral (sporadic) tumors is less than 2%.[<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">61</a>] Two familial Wilms tumor genes have been localized to FWT1 (17q12-q21) and FWT2 (19q13.4).[<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">62</a>,<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">63</a>,<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">64</a>]</p><p><b>Bilateral Wilms Tumor</b></p><p>About 4% to 5% of patients have bilateral Wilms tumors, but these are not usually hereditary.[<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">65</a>] Many bilateral tumors are present at the time Wilms tumor is first diagnosed (i.e., synchronous), but a second Wilms tumor may also develop later in the remaining kidney of 1% to 3% of children treated successfully for Wilms tumor. The incidence of such metachronous bilateral Wilms tumors is much higher in children whose original Wilms tumor was diagnosed before age 12 months and/or whose resected kidney contains nephrogenic rests. Periodic abdominal ultrasound is recommended for early detection of metachronous bilateral Wilms tumor as follows:[<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">63</a>,<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">64</a>]</p><ul type="disc"><li>Children with nephrogenic rests in the resected kidney (if younger than 48 months at initial diagnosis)—every 3 months for 6 years.</li><li>Children with nephrogenic rests in the resected kidney (if older than 48 months at initial diagnosis)—every 3 months for 4 years.</li><li>Other patients—every 3 months for 2 years, then yearly for an additional 1 to 3 years.</li></ul><p>Clear cell <a chronic_id="091e9c5e80d6fb11" crossLinkId="1577799" directive="friendlyurl" externalId="091e9c5e80d6fb11" href="/webmd/consumer_assets/editorial/articles/health_and_medical_reference/cancer/other_cancers/sarcoma.xml" keywordId="74428" keywordSetId="33736" object_type="wbmd_cons_article" path="/webmd/consumer_assets/editorial/articles/health_and_medical_reference/cancer/other_cancers/sarcoma.xml">sarcoma</a> of the kidney, rhabdoid tumor of the kidney, neuroepithelial tumor of the kidney, and cystic partially-differentiated nephroblastoma are childhood renal tumors unrelated to Wilms tumor.[<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">66</a>,<a chronic_id="091e9c5e800f4449" directive="friendlyurl" document-type="Nci" href="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml">67</a>] (Refer to the Cellular Classification section of this summary for more information.)</p><p><b>References: </b><br></p><ol><li><a name="s1.1"></a> Smith MA, Seibel NL, Altekruse SF, et al.: Outcomes for children and adolescents with cancer: challenges for the twenty-first century. J Clin Oncol 28 (15): 2625-34, 2010.</li><li><a name="s1.2"></a> Guidelines for the pediatric cancer center and role of such centers in diagnosis and treatment. American Academy of Pediatrics Section Statement Section on Hematology/Oncology. Pediatrics 99 (1): 139-41, 1997.</li><li><a name="s1.3"></a> Green DM, Breslow NE, Beckwith JB, et al.: Effect of duration of treatment on treatment outcome and cost of treatment for Wilms' tumor: a report from the National Wilms' Tumor Study Group. J Clin Oncol 16 (12): 3744-51, 1998.</li><li><a name="s1.4"></a> Kalapurakal JA, Dome JS, Perlman EJ, et al.: Management of Wilms' tumour: current practice and future goals. Lancet Oncol 5 (1): 37-46, 2004.</li><li><a name="s1.5"></a> Ehrlich PF: Wilms tumor: progress and considerations for the surgeon. Surg Oncol 16 (3): 157-71, 2007.</li><li><a name="s1.6"></a> Dome JS, Cotton CA, Perlman EJ, et al.: Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study. J Clin Oncol 24 (15): 2352-8, 2006.</li><li><a name="s1.7"></a> Shamberger RC, Anderson JR, Breslow NE, et al.: Long-term outcomes for infants with very low risk Wilms tumor treated with surgery alone in National Wilms Tumor Study-5. Ann Surg 251 (3): 555-8, 2010.</li><li><a name="s1.8"></a> Popov SD, Sebire NJ, Pritchard-Jones K, et al.: Renal tumors in children aged 10-16 Years: a report from the United Kingdom Children's Cancer and Leukaemia Group. Pediatr Dev Pathol 14 (3): 189-93, 2011 May-Jun.</li><li><a name="s1.9"></a> Kalapurakal JA, Nan B, Norkool P, et al.: Treatment outcomes in adults with favorable histologic type Wilms tumor-an update from the National Wilms Tumor Study Group. Int J Radiat Oncol Biol Phys 60 (5): 1379-84, 2004.</li><li><a name="s1.10"></a> Reinhard H, Aliani S, Ruebe C, et al.: Wilms' tumor in adults: results of the Society of Pediatric Oncology (SIOP) 93-01/Society for Pediatric Oncology and Hematology (GPOH) Study. J Clin Oncol 22 (22): 4500-6, 2004.</li><li><a name="s1.11"></a> Ali AN, Diaz R, Shu HK, et al.: A Surveillance, Epidemiology and End Results (SEER) program comparison of adult and pediatric Wilms' tumor. Cancer 118 (9): 2541-51, 2012.</li><li><a name="s1.12"></a> Narod SA, Hawkins MM, Robertson CM, et al.: Congenital anomalies and childhood cancer in Great Britain. Am J Hum Genet 60 (3): 474-85, 1997.</li><li><a name="s1.13"></a> Gracia Bouthelier R, Lapunzina P: Follow-up and risk of tumors in overgrowth syndromes. J Pediatr Endocrinol Metab 18 (Suppl 1): 1227-35, 2005.</li><li><a name="s1.14"></a> Lapunzina P: Risk of tumorigenesis in overgrowth syndromes: a comprehensive review. Am J Med Genet C Semin Med Genet 137 (1): 53-71, 2005.</li><li><a name="s1.15"></a> Green DM, Breslow NE, Beckwith JB, et al.: Screening of children with hemihypertrophy, aniridia, and Beckwith-Wiedemann syndrome in patients with Wilms tumor: a report from the National Wilms Tumor Study. Med Pediatr Oncol 21 (3): 188-92, 1993.</li><li><a name="s1.16"></a> DeBaun MR, Siegel MJ, Choyke PL: Nephromegaly in infancy and early childhood: a risk factor for Wilms tumor in Beckwith-Wiedemann syndrome. J Pediatr 132 (3 Pt 1): 401-4, 1998.</li><li><a name="s1.17"></a> DeBaun MR, Tucker MA: Risk of cancer during the first four years of life in children from The Beckwith-Wiedemann Syndrome Registry. J Pediatr 132 (3 Pt 1): 398-400, 1998.</li><li><a name="s1.18"></a> Porteus MH, Narkool P, Neuberg D, et al.: Characteristics and outcome of children with Beckwith-Wiedemann syndrome and Wilms' tumor: a report from the National Wilms Tumor Study Group. J Clin Oncol 18 (10): 2026-31, 2000.</li><li><a name="s1.19"></a> Hoyme HE, Seaver LH, Jones KL, et al.: Isolated hemihyperplasia (hemihypertrophy): report of a prospective multicenter study of the incidence of neoplasia and review. Am J Med Genet 79 (4): 274-8, 1998.</li><li><a name="s1.20"></a> Greenberg F, Stein F, Gresik MV, et al.: The Perlman familial nephroblastomatosis syndrome. Am J Med Genet 24 (1): 101-10, 1986.</li><li><a name="s1.21"></a> Astuti D, Morris MR, Cooper WN, et al.: Germline mutations in DIS3L2 cause the Perlman syndrome of overgrowth and Wilms tumor susceptibility. Nat Genet 44 (3): 277-84, 2012.</li><li><a name="s1.22"></a> Clericuzio CL: Clinical phenotypes and Wilms tumor. Med Pediatr Oncol 21 (3): 182-7, 1993.</li><li><a name="s1.23"></a> Fischbach BV, Trout KL, Lewis J, et al.: WAGR syndrome: a clinical review of 54 cases. Pediatrics 116 (4): 984-8, 2005.</li><li><a name="s1.24"></a> Breslow NE, Norris R, Norkool PA, et al.: Characteristics and outcomes of children with the Wilms tumor-Aniridia syndrome: a report from the National Wilms Tumor Study Group. J Clin Oncol 21 (24): 4579-85, 2003.</li><li><a name="s1.25"></a> Barbosa AS, Hadjiathanasiou CG, Theodoridis C, et al.: The same mutation affecting the splicing of WT1 gene is present on Frasier syndrome patients with or without Wilms' tumor. Hum Mutat 13 (2): 146-53, 1999.</li><li><a name="s1.26"></a> Koziell AB, Grundy R, Barratt TM, et al.: Evidence for the genetic heterogeneity of nephropathic phenotypes associated with Denys-Drash and Frasier syndromes. Am J Hum Genet 64 (6): 1778-81, 1999.</li><li><a name="s1.27"></a> Royer-Pokora B, Beier M, Henzler M, et al.: Twenty-four new cases of WT1 germline mutations and review of the literature: genotype/phenotype correlations for Wilms tumor development. Am J Med Genet A 127 (3): 249-57, 2004.</li><li><a name="s1.28"></a> Pelletier J, Bruening W, Kashtan CE, et al.: Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell 67 (2): 437-47, 1991.</li><li><a name="s1.29"></a> Bourdeaut F, Guiochon-Mantel A, Fabre M, et al.: Alagille syndrome and nephroblastoma: Unusual coincidence of two rare disorders. Pediatr <a chronic_id="091e9c5e8056ea80" crossLinkId="1506783" directive="friendlyurl" externalId="091e9c5e8056ea80" href="/webmd/consumer_assets/editorial/articles/image_collections/anatomy_pages/anatomy_picture_of_blood.xml" keywordId="62987" keywordSetId="28544" object_type="wbmd_cons_article" path="/webmd/consumer_assets/editorial/articles/image_collections/anatomy_pages/anatomy_picture_of_blood.xml">Blood</a> Cancer 50 (4): 908-11, 2008.</li><li><a name="s1.30"></a> Scott RH, Walker L, Olsen ØE, et al.: Surveillance for Wilms tumour in at-risk children: pragmatic recommendations for best practice. Arch Dis Child 91 (12): 995-9, 2006.</li><li><a name="s1.31"></a> Tan TY, Amor DJ: Tumour surveillance in Beckwith-Wiedemann syndrome and hemihyperplasia: a critical review of the evidence and suggested guidelines for local practice. J Paediatr Child Health 42 (9): 486-90, 2006.</li><li><a name="s1.32"></a> Teplick A, Kowalski M, Biegel JA, et al.: Educational paper: screening in cancer predisposition syndromes: guidelines for the general pediatrician. Eur J Pediatr 170 (3): 285-94, 2011.</li><li><a name="s1.33"></a> Greene AK, Kieran M, Burrows PE, et al.: Wilms tumor screening is unnecessary in Klippel-Trenaunay syndrome. Pediatrics 113 (4): e326-9, 2004.</li><li><a name="s1.34"></a> Little SE, Hanks SP, King-Underwood L, et al.: Frequency and heritability of WT1 mutations in nonsyndromic Wilms' tumor patients: a UK Children's Cancer Study Group Study. J Clin Oncol 22 (20): 4140-6, 2004.</li><li><a name="s1.35"></a> Grønskov K, Olsen JH, Sand A, et al.: Population-based risk estimates of Wilms tumor in sporadic aniridia. A comprehensive mutation screening procedure of PAX6 identifies 80% of mutations in aniridia. Hum Genet 109 (1): 11-8, 2001.</li><li><a name="s1.36"></a> Scott RH, Douglas J, Baskcomb L, et al.: Constitutional 11p15 abnormalities, including heritable imprinting center mutations, cause nonsyndromic Wilms tumor. Nat Genet 40 (11): 1329-34, 2008.</li><li><a name="s1.37"></a> Lange J, Peterson SM, Takashima JR, et al.: Risk factors for end stage renal disease in non-WT1-syndromic Wilms tumor. J Urol 186 (2): 378-86, 2011.</li><li><a name="s1.38"></a> Breslow NE, Takashima JR, Ritchey ML, et al.: Renal failure in the Denys-Drash and Wilms' tumor-aniridia syndromes. Cancer Res 60 (15): 4030-2, 2000.</li><li><a name="s1.39"></a> Maiti S, Alam R, Amos CI, et al.: Frequent association of beta-catenin and WT1 mutations in Wilms tumors. Cancer Res 60 (22): 6288-92, 2000.</li><li><a name="s1.40"></a> Koesters R, Ridder R, Kopp-Schneider A, et al.: Mutational activation of the beta-catenin proto-oncogene is a common event in the development of Wilms' tumors. Cancer Res 59 (16): 3880-2, 1999.</li><li><a name="s1.41"></a> Ruteshouser EC, Robinson SM, Huff V: Wilms tumor genetics: mutations in WT1, WTX, and CTNNB1 account for only about one-third of tumors. Genes Chromosomes Cancer 47 (6): 461-70, 2008.</li><li><a name="s1.42"></a> Major MB, Camp ND, Berndt JD, et al.: Wilms tumor suppressor WTX negatively regulates WNT/beta-catenin signaling. Science 316 (5827): 1043-6, 2007.</li><li><a name="s1.43"></a> Perlman EJ, Grundy PE, Anderson JR, et al.: WT1 mutation and 11P15 loss of heterozygosity predict relapse in very low-risk wilms tumors treated with surgery alone: a children's oncology group study. J Clin Oncol 29 (6): 698-703, 2011.</li><li><a name="s1.44"></a> Algar EM, St Heaps L, Darmanian A, et al.: Paternally inherited submicroscopic duplication at 11p15.5 implicates <a chronic_id="" crossLinkId="65592" directive="friendlyurl" externalId="5233" href="http://www.webmd.com/drugs/drug-5233-Insulin+Regular+Human+Inj.aspx?drugid=5233&amp;drugname=Insulin+Regular+Human+Inj" keywordId="54068" keywordSetId="21659" object_type="" path="/webmdhttp://www.webmd.com/drugs/drug-5233-Insulin+Regular+Human+Inj.aspx?drugid=5233&amp;drugname=Insulin+Regular+Human+Inj">insulin</a>-like growth factor II in overgrowth and Wilms' tumorigenesis. Cancer Res 67 (5): 2360-5, 2007.</li><li><a name="s1.45"></a> Satoh Y, Nakadate H, Nakagawachi T, et al.: Genetic and epigenetic alterations on the short arm of chromosome 11 are involved in a majority of sporadic Wilms' tumours. Br J Cancer 95 (4): 541-7, 2006.</li><li><a name="s1.46"></a> Bjornsson HT, Brown LJ, Fallin MD, et al.: Epigenetic specificity of loss of imprinting of the IGF2 gene in Wilms tumors. J Natl Cancer Inst 99 (16): 1270-3, 2007.</li><li><a name="s1.47"></a> Fukuzawa R, Breslow NE, Morison IM, et al.: Epigenetic differences between Wilms' tumours in white and east-Asian children. Lancet 363 (9407): 446-51, 2004.</li><li><a name="s1.48"></a> Bliek J, Gicquel C, Maas S, et al.: Epigenotyping as a tool for the prediction of tumor risk and tumor type in patients with Beckwith-Wiedemann syndrome (BWS). J Pediatr 145 (6): 796-9, 2004.</li><li><a name="s1.49"></a> Dome J, Perlman E, Ritchey M, et al.: Renal tumors. In: Pizzo P, Poplack D: Principles and Practice of Pediatric Oncology. 5th ed. Philadelphia, Pa: Lippincott Williams and Wilkins, 2005, pp 905-32.</li><li><a name="s1.50"></a> Breslow N, Olshan A, Beckwith JB, et al.: Epidemiology of Wilms tumor. Med Pediatr Oncol 21 (3): 172-81, 1993.</li><li><a name="s1.51"></a> Wegert J, Wittmann S, Leuschner I, et al.: WTX inactivation is a frequent, but late event in Wilms tumors without apparent clinical impact. Genes Chromosomes Cancer 48 (12): 1102-11, 2009.</li><li><a name="s1.52"></a> Rivera MN, Kim WJ, Wells J, et al.: An X chromosome gene, WTX, is commonly inactivated in Wilms tumor. Science 315 (5812): 642-5, 2007.</li><li><a name="s1.53"></a> Grundy PE, Breslow NE, Li S, et al.: Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group. J Clin Oncol 23 (29): 7312-21, 2005.</li><li><a name="s1.54"></a> Natrajan R, Little SE, Reis-Filho JS, et al.: Amplification and overexpression of CACNA1E correlates with relapse in favorable histology Wilms' tumors. Clin Cancer Res 12 (24): 7284-93, 2006.</li><li><a name="s1.55"></a> Blish KR, Clausen KA, Hawkins GA, et al.: Loss of heterozygosity and SOSTDC1 in adult and pediatric renal tumors. J Exp Clin Cancer Res 29: 147, 2010.</li><li><a name="s1.56"></a> Singh KP, Roy D: SKCG-1: a new candidate growth regulatory gene at chromosome 11q23.2 in human sporadic Wilms tumours. Br J Cancer 94 (10): 1524-32, 2006.</li><li><a name="s1.57"></a> Bardeesy N, Falkoff D, Petruzzi MJ, et al.: Anaplastic Wilms' tumour, a subtype displaying poor prognosis, harbours p53 gene mutations. Nat Genet 7 (1): 91-7, 1994.</li><li><a name="s1.58"></a> el Bahtimi R, Hazen-Martin DJ, Re GG, et al.: Immunophenotype, mRNA expression, and gene structure of p53 in Wilms' tumors. Mod Pathol 9 (3): 238-44, 1996.</li><li><a name="s1.59"></a> Williams RD, Al-Saadi R, Chagtai T, et al.: Subtype-specific FBXW7 mutation and MYCN copy number gain in Wilms' tumor. Clin Cancer Res 16 (7): 2036-45, 2010.</li><li><a name="s1.60"></a> Bonaïti-Pellié C, Chompret A, Tournade MF, et al.: Genetics and epidemiology of Wilms' tumor: the French Wilms' tumor study. Med Pediatr Oncol 20 (4): 284-91, 1992.</li><li><a name="s1.61"></a> Li FP, Williams WR, Gimbrere K, et al.: Heritable fraction of unilateral Wilms tumor. Pediatrics 81 (1): 147-9, 1988.</li><li><a name="s1.62"></a> Ruteshouser EC, Huff V: Familial Wilms tumor. Am J Med Genet C Semin Med Genet 129 (1): 29-34, 2004.</li><li><a name="s1.63"></a> Paulino AC, Thakkar B, Henderson WG: Metachronous bilateral Wilms' tumor: the importance of time interval to the development of a second tumor. Cancer 82 (2): 415-20, 1998.</li><li><a name="s1.64"></a> Coppes MJ, Arnold M, Beckwith JB, et al.: Factors affecting the risk of contralateral Wilms tumor development: a report from the National Wilms Tumor Study Group. Cancer 85 (7): 1616-25, 1999.</li><li><a name="s1.65"></a> Breslow NE, Beckwith JB: Epidemiological features of Wilms' tumor: results of the National Wilms' Tumor Study. J Natl Cancer Inst 68 (3): 429-36, 1982.</li><li><a name="s1.66"></a> Ahmed HU, Arya M, Levitt G, et al.: Part I: Primary malignant non-Wilms' renal tumours in children. Lancet Oncol 8 (8): 730-7, 2007.</li><li><a name="s1.67"></a> Ahmed HU, Arya M, Levitt G, et al.: Part II: Treatment of primary malignant non-Wilms' renal tumours in children. Lancet Oncol 8 (9): 842-8, 2007.</li></ol></section_text></section_group></page></pages><citations></citations><related_links_type></related_links_type><related_links_header></related_links_header><related_links_text></related_links_text></cons_import_health_ref></content_section></wbmd_asset></content><friendlyurls><target siteid="3" name="WebMD" issearchable="true" prefix="www" friendlyurl="/cancer/tc/wilms-tumor-treatment-health-professional-information-nci-pdq-general-information" owner="false"><breadcrumb><bread piece="Cancer Health Center" prefix="www" friendlyurl="/cancer/default.htm"></bread><bread piece="Cancer Related Topics" prefix="www" friendlyurl="/cancer/tc/default.htm"></bread></breadcrumb><centers><Topic id="1146" name="tmg" chronicid="091e9c5e80e70962" prefix="www" friendlyurl="/cancer/tc/wilms-tumor-and-other-childhood-kidney-tumors-treatment-pdq-treatment&amp;#45;&amp;#45;-health-professional-information-nci-nci_ncicdr0000062789-nci-header" type="Topic">Wilms Tumor and Other Childhood Kidney Tumors Treatment (PDQ®): Treatment - Health Professional Information [NCI]</Topic><Super id="848" name="super center" chronicid="091e9c5e80024a11" prefix="www" friendlyurl="/cancer/default.htm" type="">Cancer</Super></centers></target><target siteid="8" name="WebMD_Mobile" issearchable="true" prefix="www" friendlyurl="/a-to-z-guides/tc/wilms-tumor-treatment-health-professional-information-nci-pdq-general-information" owner="false"><breadcrumb><bread piece="A to Z Guides" prefix="www" friendlyurl="/a-to-z-guides/default.htm"></bread><bread piece="Related Topics" prefix="www" friendlyurl="/a-to-z-guides/tc/default.htm"></bread></breadcrumb><centers><Topic id="11198" name="tmg" chronicid="091e9c5e80e70962" prefix="www" friendlyurl="/a-to-z-guides/tc/wilms-tumor-and-other-childhood-kidney-tumors-treatment-pdq-treatment&amp;#45;&amp;#45;-health-professional-information-nci-nci_ncicdr0000062789-nci-header" type="Topic">Wilms Tumor and Other Childhood Kidney Tumors Treatment (PDQ®): Treatment - Health Professional Information [NCI]</Topic></centers></target></friendlyurls><referenced_objects><object chronic_id="091e9c5e800f4449" thmbnl="" pointer="0" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.wxml"><target siteid="3" name="WebMD" prefix="www" friendlyurl="/cancer/tc/wilms-tumor-treatment-health-professional-information-nci-pdq-general-information"></target><target siteid="8" name="WebMD_Mobile" prefix="www" friendlyurl="/a-to-z-guides/tc/wilms-tumor-treatment-health-professional-information-nci-pdq-general-information"></target></object><object chronic_id="091e9c5e804d6f9a" thmbnl="" pointer="0" path="/webmd/consumer_assets/editorial/articles/health_and_medical_reference/cancer/miscellaneous/what_to_expect_from_radiation_therapy.wxml"><target siteid="3" name="WebMD" prefix="www" friendlyurl="/cancer/what-to-expect-from-radiation-therapy"></target><target siteid="8" name="WebMD_Mobile" prefix="www" friendlyurl="/a-to-z-guides/what-to-expect-from-radiation-therapy"></target></object><object chronic_id="091e9c5e8070f589" thmbnl="" pointer="0" path="/webmd/consumer_assets/editorial/articles/health_and_medical_reference/childrens_health/miscellaneous/intellectual_disability_mental_retardation.wxml"><target siteid="3" name="WebMD" prefix="www" friendlyurl="/children/intellectual-disability-mental-retardation"></target><target siteid="8" name="WebMD_Mobile" prefix="www" friendlyurl="/children/intellectual-disability-mental-retardation"></target></object><object chronic_id="091e9c5e8001ef67" thmbnl="" pointer="0" path="/webmd/consumer_assets/controlled_content/healthwise/nord/ovotesticular_disorder_of_sex_development_nord_nord772.wxml"><target siteid="3" name="WebMD" prefix="www" friendlyurl="/sexual-conditions/hermaphroditism-true"></target><target siteid="8" name="WebMD_Mobile" prefix="www" friendlyurl="/sexual-conditions/hermaphroditism-true"></target></object><object chronic_id="091e9c5e8001e1cd" thmbnl="" pointer="0" path="/webmd/consumer_assets/controlled_content/healthwise/major/Nephrotic_Syndrome-Topic_Overview.wxml"><target siteid="3" name="WebMD" prefix="www" friendlyurl="/a-to-z-guides/nephrotic-syndrome-topic-overview"></target><target siteid="8" name="WebMD_Mobile" prefix="www" friendlyurl="/a-to-z-guides/tc/nephrotic-syndrome-topic-overview"></target></object><object chronic_id="091e9c5e807f0f5b" thmbnl="" pointer="0" path="/webmd/consumer_assets/controlled_content/healthwise/special/acute_kidney_injury-topic_overview_special_aa115364.wxml"><target siteid="3" name="WebMD" prefix="www" friendlyurl="/a-to-z-guides/acute-renal-failure-topic-overview"></target><target siteid="8" name="WebMD_Mobile" prefix="www" friendlyurl="/a-to-z-guides/tc/acute-renal-failure-topic-overview"></target></object><object chronic_id="091e9c5e809b2719" thmbnl="" pointer="0" path="/webmd/consumer_assets/editorial/articles/health_and_medical_reference/childrens_health/what_is_trisomy_18.wxml"><target siteid="3" name="WebMD" prefix="www" friendlyurl="/baby/what-is-trisomy-18"></target><target siteid="8" name="WebMD_Mobile" prefix="www" friendlyurl="/baby/what-is-trisomy-18"></target></object><object chronic_id="091e9c5e80743115" thmbnl="" pointer="0" path="/webmd/consumer_assets/editorial/articles/health_and_medical_reference/healthy_living/miscellaneous/What_Is_an_Ultrasound.wxml"><target siteid="3" name="WebMD" prefix="www" friendlyurl="/a-to-z-guides/what-is-an-ultrasound"></target><target siteid="8" name="WebMD_Mobile" prefix="www" friendlyurl="/a-to-z-guides/what-is-an-ultrasound"></target></object><object chronic_id="091e9c5e80348a30" thmbnl="" pointer="0" path="/webmd/consumer_assets/editorial/articles/image_collections/anatomy_pages/liver_2.wxml"><target siteid="3" name="WebMD" prefix="www" friendlyurl="/digestive-disorders/picture-of-the-liver"></target><target siteid="8" name="WebMD_Mobile" prefix="www" friendlyurl="/a-to-z-guides/picture-of-the-liver"></target></object><object chronic_id="091e9c5e8001f09d" thmbnl="" pointer="0" path="/webmd/consumer_assets/controlled_content/healthwise/medicaltest/abdominal_ultrasound_medicaltest_hw1430.wxml"><target siteid="3" name="WebMD" prefix="www" friendlyurl="/digestive-disorders/abdominal-ultrasound"></target><target siteid="8" name="WebMD_Mobile" prefix="www" friendlyurl="/a-to-z-guides/abdominal-ultrasound"></target></object><object chronic_id="091e9c5e803f72c0" thmbnl="" pointer="0" path="/webmd/consumer_assets/editorial/articles/image_collections/anatomy_pages/picture_of_the_kidneys.wxml"><target siteid="3" name="WebMD" prefix="www" friendlyurl="/urinary-incontinence-oab/picture-of-the-kidneys"></target><target siteid="8" name="WebMD_Mobile" prefix="www" friendlyurl="/a-to-z-guides/picture-of-the-kidneys"></target></object><object chronic_id="091e9c5e8041fa4e" thmbnl="" pointer="0" path="/webmd/consumer_assets/editorial/articles/image_collections/anatomy_pages/picture_of_the_brain.wxml"><target siteid="3" name="WebMD" prefix="www" friendlyurl="/brain/picture-of-the-brain"></target><target siteid="8" name="WebMD_Mobile" prefix="www" friendlyurl="/a-to-z-guides/picture-of-the-brain"></target></object><object chronic_id="091e9c5e800232f5" thmbnl="" pointer="0" path="/webmd/PageBuilder_Assets/scopemaps/WebMD Consumer/Pages/Hypertension Health Center/page_Hypertension Health Center_091e9c5e800232f5.wxml"><target siteid="3" name="WebMD" prefix="www" friendlyurl="/hypertension-high-blood-pressure/default.htm" umtchronicleid="091e9c5e807bd3c1"></target><target siteid="8" name="" prefix="www" friendlyurl="/a-to-z-guides/high-blood-pressure-treatment-directory" umtchronicleid="091e9c5e807bd3c1"></target></object><object chronic_id="091e9c5e80d59ba7" thmbnl="" pointer="0" path="/webmd/consumer_assets/editorial/articles/health_and_medical_reference/cancer/miscellaneous/chemotherapy_what_expect.wxml"><target siteid="3" name="WebMD" prefix="www" friendlyurl="/cancer/chemotherapy-what-to-expect"></target><target siteid="8" name="WebMD_Mobile" prefix="www" friendlyurl="/a-to-z-guides/chemotherapy-what-to-expect"></target></object><object chronic_id="091e9c5e80d6fb11" thmbnl="" pointer="0" path="/webmd/consumer_assets/editorial/articles/health_and_medical_reference/cancer/other_cancers/sarcoma.wxml"><target siteid="3" name="WebMD" prefix="www" friendlyurl="/cancer/sarcoma"></target><target siteid="8" name="WebMD_Mobile" prefix="www" friendlyurl="/a-to-z-guides/sarcoma"></target></object><object chronic_id="091e9c5e8056ea80" thmbnl="" pointer="0" path="/webmd/consumer_assets/editorial/articles/image_collections/anatomy_pages/anatomy_picture_of_blood.wxml"><target siteid="3" name="WebMD" prefix="www" friendlyurl="/heart/anatomy-picture-of-blood"></target><target siteid="8" name="WebMD_Mobile" prefix="www" friendlyurl="/a-to-z-guides/anatomy-picture-of-blood"></target></object><object chronic_id="091e9c5e80e70962" thmbnl="" pointer="0" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-nci_ncicdr0000062789-nci-header_nci_ncicdr0000062789-nci-header.wxml"><target siteid="3" name="WebMD" prefix="www" friendlyurl="/cancer/tc/wilms-tumor-and-other-childhood-kidney-tumors-treatment-pdq-treatment&amp;#45;&amp;#45;-health-professional-information-nci-nci_ncicdr0000062789-nci-header"></target><target siteid="8" name="WebMD_Mobile" prefix="www" friendlyurl="/a-to-z-guides/tc/wilms-tumor-and-other-childhood-kidney-tumors-treatment-pdq-treatment&amp;#45;&amp;#45;-health-professional-information-nci-nci_ncicdr0000062789-nci-header"></target></object><object chronic_id="091e9c5e800f4449" thmbnl="" pointer="0" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.wxml"><target siteid="3" name="WebMD" prefix="www" friendlyurl="/cancer/tc/wilms-tumor-treatment-health-professional-information-nci-pdq-general-information"></target><target siteid="8" name="WebMD_Mobile" prefix="www" friendlyurl="/a-to-z-guides/tc/wilms-tumor-treatment-health-professional-information-nci-pdq-general-information"></target></object><object chronic_id="091e9c5e800f444a" thmbnl="" pointer="0" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-cellular_classification_nci_ncicdr0000062789-cellular-classification.wxml"><target siteid="3" name="WebMD" prefix="www" friendlyurl="/cancer/tc/wilms-tumor-treatment-health-professional-information-nci-pdq-cellular-classification"></target><target siteid="8" name="WebMD_Mobile" prefix="www" friendlyurl="/a-to-z-guides/tc/wilms-tumor-treatment-health-professional-information-nci-pdq-cellular-classification"></target></object><object chronic_id="091e9c5e800f444b" thmbnl="" pointer="0" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-stage_information_nci_ncicdr0000062789-stage-information.wxml"><target siteid="3" name="WebMD" prefix="www" friendlyurl="/cancer/tc/wilms-tumor-treatment-health-professional-information-nci-pdq-stage-information"></target><target siteid="8" name="WebMD_Mobile" prefix="www" friendlyurl="/a-to-z-guides/tc/wilms-tumor-treatment-health-professional-information-nci-pdq-stage-information"></target></object><object chronic_id="091e9c5e800f444c" thmbnl="" pointer="0" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-treatment_option_overview_nci_ncicdr0000062789-treatment-option-overview.wxml"><target siteid="3" name="WebMD" prefix="www" friendlyurl="/cancer/tc/wilms-tumor-treatment-health-professional-information-nci-pdq-treatment-option-overview"></target><target siteid="8" name="WebMD_Mobile" prefix="www" friendlyurl="/a-to-z-guides/tc/wilms-tumor-treatment-health-professional-information-nci-pdq-treatment-option-overview"></target></object><object chronic_id="091e9c5e807f0a5a" thmbnl="" pointer="0" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-treatment_of_wilms_tumor_nci_ncicdr0000062789-treatment-of-wilms-tumor.wxml"><target siteid="3" name="WebMD" prefix="www" friendlyurl="/cancer/tc/ncicdr0000062789-treatment-of-wilms-tumor"></target><target siteid="8" name="WebMD_Mobile" prefix="www" friendlyurl="/a-to-z-guides/tc/ncicdr0000062789-treatment-of-wilms-tumor"></target></object><object chronic_id="091e9c5e807f0a61" thmbnl="" pointer="0" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-treatment_of_clear_cell_sarcoma_of_the_kidney_nci_ncicdr0000062789-treatment-of-clear-cell-sarcoma-of-the-kidney.wxml"><target siteid="3" name="WebMD" prefix="www" friendlyurl="/cancer/tc/ncicdr0000062789-treatment-of-clear-cell-sarcoma-of-the-kidney"></target><target siteid="8" name="WebMD_Mobile" prefix="www" friendlyurl="/a-to-z-guides/tc/ncicdr0000062789-treatment-of-clear-cell-sarcoma-of-the-kidney"></target></object><object chronic_id="091e9c5e807f0a62" thmbnl="" pointer="0" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-treatment_of_rhabdoid_tumor_of_the_kidney_nci_ncicdr0000062789-treatment-of-rhabdoid-tumor-of-the-kidney.wxml"><target siteid="3" name="WebMD" prefix="www" friendlyurl="/cancer/tc/ncicdr0000062789-treatment-of-rhabdoid-tumor-of-the-kidney"></target><target siteid="8" name="WebMD_Mobile" prefix="www" friendlyurl="/a-to-z-guides/tc/ncicdr0000062789-treatment-of-rhabdoid-tumor-of-the-kidney"></target></object><object chronic_id="091e9c5e807f0a63" thmbnl="" pointer="0" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-treatment_of_neuroepithelial_tumor_of_the_kidney_nci_ncicdr0000062789-treatment-of-neuroepithelial-tumor-of-the-kidney.wxml"><target siteid="3" name="WebMD" prefix="www" friendlyurl="/cancer/tc/ncicdr0000062789-treatment-of-neuroepithelial-tumor-of-the-kidney"></target><target siteid="8" name="WebMD_Mobile" prefix="www" friendlyurl="/a-to-z-guides/tc/ncicdr0000062789-treatment-of-neuroepithelial-tumor-of-the-kidney"></target></object><object chronic_id="091e9c5e807f0a64" thmbnl="" pointer="0" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-treatment_of_congenital_mesoblastic_nephroma_nci_ncicdr0000062789-treatment-of-congenital-mesoblastic-nephroma.wxml"><target siteid="3" name="WebMD" prefix="www" friendlyurl="/cancer/tc/ncicdr0000062789-treatment-of-congenital-mesoblastic-nephroma"></target><target siteid="8" name="WebMD_Mobile" prefix="www" friendlyurl="/a-to-z-guides/tc/ncicdr0000062789-treatment-of-congenital-mesoblastic-nephroma"></target></object><object chronic_id="091e9c5e807f0a65" thmbnl="" pointer="0" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-treatment_of_renal_cell_carcinoma_nci_ncicdr0000062789-treatment-of-renal-cell-carcinoma.wxml"><target siteid="3" name="WebMD" prefix="www" friendlyurl="/cancer/tc/ncicdr0000062789-treatment-of-renal-cell-carcinoma"></target><target siteid="8" name="WebMD_Mobile" prefix="www" friendlyurl="/a-to-z-guides/tc/ncicdr0000062789-treatment-of-renal-cell-carcinoma"></target></object><object chronic_id="091e9c5e807f0a66" thmbnl="" pointer="0" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-treatment_of_recurrent_wilms_tumor_and_other_childhoo_nci_ncicdr0000062789-treatment-of-recurrent-wilms-tumor-and-other-childhood-kidney-tumors.wxml"><target siteid="3" name="WebMD" prefix="www" friendlyurl="/cancer/tc/ncicdr0000062789-treatment-of-recurrent-wilms-tumor-and-other-childhood-kidney-tumors"></target><target siteid="8" name="WebMD_Mobile" prefix="www" friendlyurl="/a-to-z-guides/tc/ncicdr0000062789-treatment-of-recurrent-wilms-tumor-and-other-childhood-kidney-tumors"></target></object><object chronic_id="091e9c5e80e6bb0e" thmbnl="" pointer="0" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-changes_to_this_summary_11__27__2012_nci_ncicdr0000062789-changes-to-this-summary-11272012.wxml"><target siteid="3" name="WebMD" prefix="www" friendlyurl="/cancer/tc/wilms-tumor-and-other-childhood-kidney-tumors-treatment-pdq-treatment&amp;#45;&amp;#45;-health-professional-information-nci-changes-to-this-summary-11&amp;#45;&amp;#45;27&amp;#45;&amp;#45;2012"></target><target siteid="8" name="WebMD_Mobile" prefix="www" friendlyurl="/a-to-z-guides/tc/wilms-tumor-and-other-childhood-kidney-tumors-treatment-pdq-treatment&amp;#45;&amp;#45;-health-professional-information-nci-changes-to-this-summary-11&amp;#45;&amp;#45;27&amp;#45;&amp;#45;2012"></target></object><object chronic_id="091e9c5e807f0a67" thmbnl="" pointer="0" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-about_this_pdq_summary_nci_ncicdr0000062789-about-this-pdq-summary.wxml"><target siteid="3" name="WebMD" prefix="www" friendlyurl="/cancer/tc/ncicdr0000062789-about-this-pdq-summary"></target><target siteid="8" name="WebMD_Mobile" prefix="www" friendlyurl="/a-to-z-guides/tc/ncicdr0000062789-about-this-pdq-summary"></target></object><object chronic_id="091e9c5e80249224" thmbnl="" pointer="0" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-get_more_information_from_nci_nci_ncicdr0000062789-get-more-information-from-nci.wxml"><target siteid="3" name="WebMD" prefix="www" friendlyurl="/cancer/tc/ncicdr0000062789-get-more-information-from-nci"></target><target siteid="8" name="WebMD_Mobile" prefix="www" friendlyurl="/a-to-z-guides/tc/ncicdr0000062789-get-more-information-from-nci"></target></object></referenced_objects><container_hierarchy></container_hierarchy><topic_outline chronic_id="091e9c5e800f4709" path="/webmd/consumer_assets/controlled_content/healthwise/toc/nci/ncicdr0000062789_nci_ncicdr0000062789.wxml"></topic_outline><expanded_objects></expanded_objects><cons_topic_outline><section_groups><section_group><section_title>Nci</section_title><section_type>Float</section_type><section_link directive="article" chronic_id="091e9c5e80e70962" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-nci_ncicdr0000062789-nci-header_nci_ncicdr0000062789-nci-header.xml" object_type="wbmd_cons_article"></section_link></section_group><section_group><section_title>General Information</section_title><section_type>Vendor</section_type><section_link directive="article" chronic_id="091e9c5e800f4449" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-general_information_nci_ncicdr0000062789-general-information.xml" object_type="wbmd_cons_article"></section_link></section_group><section_group><section_title>Cellular Classification</section_title><section_type>Vendor</section_type><section_link directive="article" chronic_id="091e9c5e800f444a" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-cellular_classification_nci_ncicdr0000062789-cellular-classification.xml" object_type="wbmd_cons_article"></section_link></section_group><section_group><section_title>Stage Information</section_title><section_type>Vendor</section_type><section_link directive="article" chronic_id="091e9c5e800f444b" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-stage_information_nci_ncicdr0000062789-stage-information.xml" object_type="wbmd_cons_article"></section_link></section_group><section_group><section_title>Treatment Option Overview</section_title><section_type>Vendor</section_type><section_link directive="article" chronic_id="091e9c5e800f444c" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-treatment_option_overview_nci_ncicdr0000062789-treatment-option-overview.xml" object_type="wbmd_cons_article"></section_link></section_group><section_group><section_title>Treatment of Wilms Tumor</section_title><section_type>Vendor</section_type><section_link directive="article" chronic_id="091e9c5e807f0a5a" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-treatment_of_wilms_tumor_nci_ncicdr0000062789-treatment-of-wilms-tumor.xml" object_type="wbmd_cons_article"></section_link></section_group><section_group><section_title>Treatment of Clear Cell Sarcoma of the Kidney</section_title><section_type>Vendor</section_type><section_link directive="article" chronic_id="091e9c5e807f0a61" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-treatment_of_clear_cell_sarcoma_of_the_kidney_nci_ncicdr0000062789-treatment-of-clear-cell-sarcoma-of-the-kidney.xml" object_type="wbmd_cons_article"></section_link></section_group><section_group><section_title>Treatment of Rhabdoid Tumor of the Kidney</section_title><section_type>Vendor</section_type><section_link directive="article" chronic_id="091e9c5e807f0a62" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-treatment_of_rhabdoid_tumor_of_the_kidney_nci_ncicdr0000062789-treatment-of-rhabdoid-tumor-of-the-kidney.xml" object_type="wbmd_cons_article"></section_link></section_group><section_group><section_title>Treatment of Neuroepithelial Tumor of the Kidney</section_title><section_type>Vendor</section_type><section_link directive="article" chronic_id="091e9c5e807f0a63" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-treatment_of_neuroepithelial_tumor_of_the_kidney_nci_ncicdr0000062789-treatment-of-neuroepithelial-tumor-of-the-kidney.xml" object_type="wbmd_cons_article"></section_link></section_group><section_group><section_title>Treatment of Congenital Mesoblastic Nephroma</section_title><section_type>Vendor</section_type><section_link directive="article" chronic_id="091e9c5e807f0a64" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-treatment_of_congenital_mesoblastic_nephroma_nci_ncicdr0000062789-treatment-of-congenital-mesoblastic-nephroma.xml" object_type="wbmd_cons_article"></section_link></section_group><section_group><section_title>Treatment of Renal Cell Carcinoma</section_title><section_type>Vendor</section_type><section_link directive="article" chronic_id="091e9c5e807f0a65" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-treatment_of_renal_cell_carcinoma_nci_ncicdr0000062789-treatment-of-renal-cell-carcinoma.xml" object_type="wbmd_cons_article"></section_link></section_group><section_group><section_title>Treatment of Recurrent Wilms Tumor and Other Childhood Kidney Tumors</section_title><section_type>Vendor</section_type><section_link directive="article" chronic_id="091e9c5e807f0a66" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-treatment_of_recurrent_wilms_tumor_and_other_childhoo_nci_ncicdr0000062789-treatment-of-recurrent-wilms-tumor-and-other-childhood-kidney-tumors.xml" object_type="wbmd_cons_article"></section_link></section_group><section_group><section_title>Changes to This Summary (11 / 27 / 2012)</section_title><section_type>Vendor</section_type><section_link directive="article" chronic_id="091e9c5e80e6bb0e" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-changes_to_this_summary_11__27__2012_nci_ncicdr0000062789-changes-to-this-summary-11272012.xml" object_type="wbmd_cons_article"></section_link></section_group><section_group><section_title>About This PDQ Summary</section_title><section_type>Vendor</section_type><section_link directive="article" chronic_id="091e9c5e807f0a67" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-about_this_pdq_summary_nci_ncicdr0000062789-about-this-pdq-summary.xml" object_type="wbmd_cons_article"></section_link></section_group><section_group><section_title>Get More Information From NCI</section_title><section_type>Vendor</section_type><section_link directive="article" chronic_id="091e9c5e80249224" path="/webmd/consumer_assets/controlled_content/healthwise/nci/ncicdr0000062789-get_more_information_from_nci_nci_ncicdr0000062789-get-more-information-from-nci.xml" object_type="wbmd_cons_article"></section_link></section_group></section_groups></cons_topic_outline><title>Wilms Tumor and Other Childhood Kidney Tumors Treatment (PDQ®): Treatment - Health Professional Information [NCI]</title><dynamic_objects><callout_title>Recommended Related to Kidney Cancer</callout_title><wbmd_asset object_type="wbmd_cons_article" id="091e9c5e80e9c9bd"><metadata_section><i_chronicle_id>091e9c5e80a75ea6</i_chronicle_id><title>To Learn More About Transitional Cell Cancer of the Renal Pelvis and Ureter</title><wbmd_c_art_thmbnl></wbmd_c_art_thmbnl></metadata_section><section_text><p>For more information from the National Cancer Institute about transitional cell cancer of the renal pelvis and ureter, see the following:

  Transitional Cell Cancer (Kidney/Ureter) Home Page
  Smoking Home Page (Includes help with quitting)

For general cancer information and other resources from the National Cancer Institute, see the following:

  What You Need to Know About™ Cancer
  Understanding Cancer Series: Cancer
  Cancer Staging
  Chemotherapy and You: Support for People With...</p></section_text><link siteid="3" prefix="www" friendlyurl="/cancer/tc/ncicdr0000343585-to-learn-more-about-transitional-cell-cancer-of-the-renal-pelvis-and-ureter"></wbmd_asset></dynamic_objects></webmd_rendition>
--> 
   <div class="article_rdr">
    <div id="textArea" class="copyNormal">
     <div class="share_bar">
      <script>webmd.m.share.init();</script>
     </div>
     <div class="font_sizer_fmt rs_skip">
      <div class="font_sizer_text_fmt">
       Font Size
      </div>
      <div class="font_sizer_001_fmt"></div>
      <div id="fs_01" class="font_sizer_002b_fmt">
       <a class="copyA_fmt" href="javascript:setClass('textArea', 'copyNormal');javascript:setClass('fs_01', 'font_sizer_002b_fmt');javascript:setClass('fs_02', 'font_sizer_002a_fmt');javascript:setClass('fs_03', 'font_sizer_002a_fmt');">A</a>
      </div>
      <div id="fs_02" class="font_sizer_002a_fmt">
       <a class="copyB_fmt" href="javascript:setClass('textArea', 'copyMedium');javascript:setClass('fs_01', 'font_sizer_002a_fmt');javascript:setClass('fs_02', 'font_sizer_002b_fmt');javascript:setClass('fs_03', 'font_sizer_002a_fmt');">A</a>
      </div>
      <div id="fs_03" class="font_sizer_002a_fmt">
       <a class="copyC_fmt" href="javascript:setClass('textArea', 'copyLarge');javascript:setClass('fs_01', 'font_sizer_002a_fmt');javascript:setClass('fs_02', 'font_sizer_002a_fmt');javascript:setClass('fs_03', 'font_sizer_002b_fmt');">A</a>
      </div>
      <div class="font_sizer_003_fmt"></div>
     </div>
     <div class="font_sizer">
      <script>webmd.m.fontSizer.init();</script>
     </div>
     <h2>Wilms Tumor and Other Childhood Kidney Tumors Treatment (PDQ&reg;): Treatment - Health Professional Information [NCI] - General Information</h2>
     <div class="hwDefinition_fmt">
      <h3> continued...</h3>
      <p>Beckwith-Wiedemann syndrome results from constitutional loss of imprinting or heterozygosity of WT2. Observations suggest genetic heterogeneity in the etiology of Beckwith-Wiedemann syndrome with differing levels of association with risk of tumor formation.[<a href="http://www.webmd.com/cancer/tc/wilms-tumor-treatment-health-professional-information-nci-pdq-general-information" onclick="return sl(this,'','embd-lnk');">48</a>] Molecularly defined subsets of Beckwith-Wiedemann patients may not require ultrasound screening for malignancies. Approximately one-fifth of patients with Beckwith-Wiedemann syndrome who develop Wilms tumor present with bilateral disease, though metachronous bilateral disease is also observed.[<a href="http://www.webmd.com/cancer/tc/wilms-tumor-treatment-health-professional-information-nci-pdq-general-information" onclick="return sl(this,'','embd-lnk');">15</a>,<a href="http://www.webmd.com/cancer/tc/wilms-tumor-treatment-health-professional-information-nci-pdq-general-information" onclick="return sl(this,'','embd-lnk');">16</a>,<a href="http://www.webmd.com/cancer/tc/wilms-tumor-treatment-health-professional-information-nci-pdq-general-information" onclick="return sl(this,'','embd-lnk');">17</a>] The prevalence of Beckwith-Wiedemann syndrome is about 1% among children with Wilms tumor reported to the NWTS.[<a href="http://www.webmd.com/cancer/tc/wilms-tumor-treatment-health-professional-information-nci-pdq-general-information" onclick="return sl(this,'','embd-lnk');">17</a>,<a href="http://www.webmd.com/cancer/tc/wilms-tumor-treatment-health-professional-information-nci-pdq-general-information" onclick="return sl(this,'','embd-lnk');">49</a>,<a href="http://www.webmd.com/cancer/tc/wilms-tumor-treatment-health-professional-information-nci-pdq-general-information" onclick="return sl(this,'','embd-lnk');">50</a>]</p>
      <p><b>Wilms tumor gene on the X chromosome(WTX)</b></p>
      <p>A third gene, WTX, has been identified on the X chromosome and plays a role in normal kidney development. WTX mutations were identified in 17% of Wilms tumors, equally distributed between males and females.[<a href="http://www.webmd.com/cancer/tc/wilms-tumor-treatment-health-professional-information-nci-pdq-general-information" onclick="return sl(this,'','embd-lnk');">51</a>] This gene is inactivated in approximately one-third of Wilms tumors but germline mutations have not been observed in patients with Wilms tumor.[<a href="http://www.webmd.com/cancer/tc/wilms-tumor-treatment-health-professional-information-nci-pdq-general-information" onclick="return sl(this,'','embd-lnk');">52</a>]</p>
      <p><b>Other genes</b></p>
      <p>Additional genes have been implicated in the pathogenesis and biology of Wilms tumor:</p>
      <ul type="disc">
       <li><b>16q and 1p:</b> Additional tumor-suppressor or tumor-progressive genes may lie on chromosomes 16q and 1p as evidenced by loss of heterozygosity for these regions in 17% and 11% of Wilms tumors, respectively. Patients classified by tumor-specific loss of these loci had significantly worse relapse-free and OS rates. Combined loss of 1p and 16q are used to select favorable-histology Wilms tumor patients for more aggressive therapy in the current Children's Oncology Group study.[<a href="http://www.webmd.com/cancer/tc/wilms-tumor-treatment-health-professional-information-nci-pdq-general-information" onclick="return sl(this,'','embd-lnk');">53</a>]</li>
       <li><b>CACNA1E:</b> Overexpression and amplification of the gene CACNA1E located at 1q25.3, which encodes the ion-conducting alpha-1 subunit of R-type voltage-dependent <a onclick="return sl(this,'','embd-lnk');" href="http://www.webmd.com/vitamins-supplements/ingredientmono-781-calcium.aspx?activeingredientid=781&amp;activeingredientname=calcium">calcium</a> channels, may be associated with relapse in favorable-histology Wilms tumor.[<a href="http://www.webmd.com/cancer/tc/wilms-tumor-treatment-health-professional-information-nci-pdq-general-information" onclick="return sl(this,'','embd-lnk');">54</a>]</li>
       <li><b>7p21:</b> A consensus region of loss of heterozygosity has been identified within 7p21 containing ten known genes, including two candidate suppressor genes (Mesenchyme homeobox 2 [MEOX2] and Sclerostin domain containing 1 [SOSTDC1]).[<a href="http://www.webmd.com/cancer/tc/wilms-tumor-treatment-health-professional-information-nci-pdq-general-information" onclick="return sl(this,'','embd-lnk');">55</a>]</li>
       <li><b>SKCG-1:</b> Genomic loss of a growth regulatory gene, SKCG-1, located at 11q23.2, was found in 38% of examined sporadic Wilms tumors and particularly the highly proliferative Wilms tumors. Additional studies of si-RNA silencing of the SKCG-1 gene in human embryonic kidney epithelial cells resulted in a 40% increase in cell growth, which suggests that this gene may be involved in loss of growth regulation and Wilms tumorigenesis.[<a href="http://www.webmd.com/cancer/tc/wilms-tumor-treatment-health-professional-information-nci-pdq-general-information" onclick="return sl(this,'','embd-lnk');">56</a>]</li>
       <li><b>p53</b> tumor suppressor gene: A small subset of anaplastic Wilms tumors show mutations in the p53 tumor suppressor gene. Although it is unlikely that it plays a major role in Wilms tumorigenesis, it may be useful as an unfavorable prognostic marker.[<a href="http://www.webmd.com/cancer/tc/wilms-tumor-treatment-health-professional-information-nci-pdq-general-information" onclick="return sl(this,'','embd-lnk');">57</a>,<a href="http://www.webmd.com/cancer/tc/wilms-tumor-treatment-health-professional-information-nci-pdq-general-information" onclick="return sl(this,'','embd-lnk');">58</a>]</li>
       <li><b>FBXW7:</b> FBXW7, a ubiquitin ligase component, has been identified as a novel Wilms tumor gene. Mutations of this gene have been associated with epithelial-type tumor histology.[<a href="http://www.webmd.com/cancer/tc/wilms-tumor-treatment-health-professional-information-nci-pdq-general-information" onclick="return sl(this,'','embd-lnk');">59</a>]</li>
       <li><b>MYCN:</b> Genomic gain or amplification of MYCN is relatively common in Wilms tumors and associated with diffuse anaplastic histology.[<a href="http://www.webmd.com/cancer/tc/wilms-tumor-treatment-health-professional-information-nci-pdq-general-information" onclick="return sl(this,'','embd-lnk');">59</a>]</li>
      </ul>
     </div>
    </div>
   </div>
   <div class="moduleSpacer_rdr"></div>
   <div class="attribution_rdr">
    <div class="pagination_fmt">
     <div class="left_fmt">
      <div class="outline_fmt">
       <a href="?page=4">&lt; Previous Page</a>
      </div>
     </div>
     <div class="right_fmt">
      <a href="http://www.webmd.com/cancer/tc/wilms-tumor-treatment-health-professional-information-nci-pdq-general-information">1</a>
      <span class="pipe_fmt">|</span>
      <a href="?page=2">2</a>
      <span class="pipe_fmt">|</span>
      <a href="?page=3">3</a>
      <span class="pipe_fmt">|</span>
      <a href="?page=4">4</a>
      <span class="pipe_fmt">|</span>
      <span class="current_fmt">5</span>
      <span class="pipe_fmt">|</span>
      <a href="?page=6">6</a>
      <div class="outline_fmt right">
       <a href="?page=6">Next Page <span class="symbol_fmt">&gt;</span></a>
      </div>
     </div>
    </div>
   </div>
   <div class="moduleSpacer_rdr"></div>
   <div class="attributionTR_rdr">
    <div class="pagination_fmt">
     <div class="left_fmt">
      <div class="outline_fmt">
       <a href="?page=4">&lt; Previous </a>
      </div>
     </div>
     <div class="right_fmt">
      <span class="pages_fmt"><a href="http://www.webmd.com/cancer/tc/wilms-tumor-treatment-health-professional-information-nci-pdq-general-information">1</a><span class="pipe_fmt">|</span><a href="?page=2">2</a><span class="pipe_fmt">|</span><a href="?page=3">3</a><span class="pipe_fmt">|</span><a href="?page=4">4</a><span class="pipe_fmt">|</span><span class="current_fmt">5</span><span class="pipe_fmt">|</span><a href="?page=6">6</a></span>
      <div class="outline_fmt right">
       <a href="?page=6"> Next <span class="symbol_fmt">&gt;</span></a>
      </div>
      <style type="text/css">
								.pagination_fmt .pages_fmt { display: none; }
                                .articlesPulldownWide_fmt { display: none; }
                                .topicArtNav_rdr { display: none; }
								.attribution_rdr .pagination_fmt { display: none; }
                                </style>
     </div>
    </div>
   </div>
   <script>$(function() {

	var currentPage = 1, ct = 0, currentTopic, a_hrefr, a_hrefl, pageParam, totalPages = 1, topics = [];
	
	/* set currentPage */
	pageParam = parseInt( webmd.url.getParam("page") );
	if ( pageParam ) {
		currentPage = pageParam;
	}
	
	/* set topics */
	
			topics.push({
			title : 'Nci',
			href : 'http://www.webmd.com/cancer/tc/wilms-tumor-and-other-childhood-kidney-tumors-treatment-pdq-treatment---health-professional-information-nci-nci_ncicdr0000062789-nci-header'
			});
            
			topics.push({
			title : 'General Information',
			href : 'http://www.webmd.com/cancer/tc/wilms-tumor-treatment-health-professional-information-nci-pdq-general-information'
			});
            
			topics.push({
			title : 'Cellular Classification',
			href : 'http://www.webmd.com/cancer/tc/wilms-tumor-treatment-health-professional-information-nci-pdq-cellular-classification'
			});
            
			topics.push({
			title : 'Stage Information',
			href : 'http://www.webmd.com/cancer/tc/wilms-tumor-treatment-health-professional-information-nci-pdq-stage-information'
			});
            
			topics.push({
			title : 'Treatment Option Overview',
			href : 'http://www.webmd.com/cancer/tc/wilms-tumor-treatment-health-professional-information-nci-pdq-treatment-option-overview'
			});
            
			topics.push({
			title : 'Treatment of Wilms Tumor',
			href : 'http://www.webmd.com/cancer/tc/ncicdr0000062789-treatment-of-wilms-tumor'
			});
            
			topics.push({
			title : 'Treatment of Clear Cell Sarcoma of the Kidney',
			href : 'http://www.webmd.com/cancer/tc/ncicdr0000062789-treatment-of-clear-cell-sarcoma-of-the-kidney'
			});
            
			topics.push({
			title : 'Treatment of Rhabdoid Tumor of the Kidney',
			href : 'http://www.webmd.com/cancer/tc/ncicdr0000062789-treatment-of-rhabdoid-tumor-of-the-kidney'
			});
            
			topics.push({
			title : 'Treatment of Neuroepithelial Tumor of the Kidney',
			href : 'http://www.webmd.com/cancer/tc/ncicdr0000062789-treatment-of-neuroepithelial-tumor-of-the-kidney'
			});
            
			topics.push({
			title : 'Treatment of Congenital Mesoblastic Nephroma',
			href : 'http://www.webmd.com/cancer/tc/ncicdr0000062789-treatment-of-congenital-mesoblastic-nephroma'
			});
            
			topics.push({
			title : 'Treatment of Renal Cell Carcinoma',
			href : 'http://www.webmd.com/cancer/tc/ncicdr0000062789-treatment-of-renal-cell-carcinoma'
			});
            
			topics.push({
			title : 'Treatment of Recurrent Wilms Tumor and Other Childhood Kidney Tumors',
			href : 'http://www.webmd.com/cancer/tc/ncicdr0000062789-treatment-of-recurrent-wilms-tumor-and-other-childhood-kidney-tumors'
			});
            
			topics.push({
			title : 'Changes to This Summary (11 / 27 / 2012)',
			href : 'http://www.webmd.com/cancer/tc/wilms-tumor-and-other-childhood-kidney-tumors-treatment-pdq-treatment---health-professional-information-nci-changes-to-this-summary-11--27--2012'
			});
            
			topics.push({
			title : 'About This PDQ Summary',
			href : 'http://www.webmd.com/cancer/tc/ncicdr0000062789-about-this-pdq-summary'
			});
            
			topics.push({
			title : 'Get More Information From NCI',
			href : 'http://www.webmd.com/cancer/tc/ncicdr0000062789-get-more-information-from-nci'
			});
            	
	
	/* set Current topic */	
	jQuery.each(topics, function(i, val) {
    if (window.location.href.indexOf(topics[i].href) > -1){
	   currentTopic = i;
	   }
    });
	

	/* if on the first article in a set, remove the previous navigation */
		if ( currentTopic == 0 ) {
			$(".pagination_fmt .left_fmt .outline_fmt").hide();
		}
		if ( window.location.href.indexOf("page=") > 1 ) {
			$(".pagination_fmt .left_fmt .outline_fmt").show();
		}

	
	/* if on the last article in a set, remove the next navigation */
	if ( (currentTopic + 1) == topics.length) {
			$(".pagination_fmt .right_fmt .outline_fmt").hide();
		
		}

/* Inserting Previous */
   if (currentTopic != 0){
   var a_hrefl = $('.pagination_fmt .left_fmt .outline_fmt a').attr('href');
   if (typeof(a_hrefl) === "undefined"){
   	$(".pagination_fmt .left_fmt .outline_fmt a").attr("href" , a_hrefl);
   } else {
    $(".pagination_fmt .left_fmt .outline_fmt a").attr("href" , topics[currentTopic - 1].href);
    }
    }


		
	/* Inserting Next */
   if ( (currentTopic + 1) != topics.length ) {
   var a_hrefr = $('.pagination_fmt .right_fmt .outline_fmt a').attr('href');
   if (typeof(a_hrefr) === "undefined"){
   $(".pagination_fmt .right_fmt .outline_fmt a").attr("href" , a_hrefr);
   }
   else if ( window.location.href.indexOf("check-your-symptoms") > -1 ) {
			$(".pagination_fmt .right_fmt .outline_fmt a").attr("href" , topics[currentTopic + 1].href);
		}
   else if (a_hrefr.indexOf('page') != -1 ) {}
   else {$(".pagination_fmt .right_fmt .outline_fmt a").attr("href" , topics[currentTopic + 1].href);}
	}
   
			
	/* Secondary pages with no data move to the next page.  */
			
	/* adding metrics to nav */
	$(".right_fmt a").on("click", function() {
		return sl(this,'','pagenum-art_next');
	});
	$(".left_fmt a").on("click", function() {
		return sl(this,'','pagenum-art_prev');
	});
	
});</script>
   <div class="moduleSpacer_rdr"></div>
   <div class="attribution_rdr">
    <div class="medicalRef_fmt">
     <p>WebMD Public Information from the National Cancer Institute</p>
     <div class="clearBoth_fmt"></div>
    </div>
    <div class="sources_fmt">
     Last Updated: February 25, 2014
    </div>
    <div class="warning_fmt">
     This information is not intended to replace the advice of a doctor. Healthwise disclaims any liability for the decisions you make based on this information.
    </div>
    <div class="basefooter_fmt"></div>
   </div>
   <div id="remoteAd_rdr">
    <div class="centerAd_r1_rdr">
     <div class="centerAd_BG_fmt">
      <div class="conta" style="color:#737373; clear:both; display:none;">
       Continue reading below...
      </div>
      <div class="remoteAd_top_fmt"></div>
      <div id="remoteAd_fmt" class="remoteAd_BG_fmt">
       <div class="ad_placeholder"></div>
      </div>
      <div class="remoteAd_bottom_fmt"></div>
     </div>
    </div>
    <div class="moduleSpacer_rdr"></div>
   </div>
   <div class="articlesPulldown_fmt articlesPulldownWide_fmt">
    <script type="text/javascript" language="javascript">
        var externalUrlList = new Array(
      'xxx');
    </script>
    <form onsubmit="return submitNavForm(externalUrlList,'NextTopicPulldown',true)">
      Next Article: 
     <select name="next_pulldown" id="NextTopicPulldown" class="pulldown_fmt"><option value="http://www.webmd.com/cancer/tc/wilms-tumor-and-other-childhood-kidney-tumors-treatment-pdq-treatment---health-professional-information-nci-nci_ncicdr0000062789-nci-header">Nci</option><option value="http://www.webmd.com/cancer/tc/wilms-tumor-treatment-health-professional-information-nci-pdq-general-information">General Information</option><option value="http://www.webmd.com/cancer/tc/wilms-tumor-treatment-health-professional-information-nci-pdq-cellular-classification">Cellular Classification</option><option value="http://www.webmd.com/cancer/tc/wilms-tumor-treatment-health-professional-information-nci-pdq-stage-information">Stage Information</option><option value="http://www.webmd.com/cancer/tc/wilms-tumor-treatment-health-professional-information-nci-pdq-treatment-option-overview">Treatment Option Overview</option><option value="http://www.webmd.com/cancer/tc/ncicdr0000062789-treatment-of-wilms-tumor">Treatment of Wilms Tumor</option><option value="http://www.webmd.com/cancer/tc/ncicdr0000062789-treatment-of-clear-cell-sarcoma-of-the-kidney">Treatment of Clear Cell Sarcoma of the Kidney</option><option value="http://www.webmd.com/cancer/tc/ncicdr0000062789-treatment-of-rhabdoid-tumor-of-the-kidney">Treatment of Rhabdoid Tumor of the Kidney</option><option value="http://www.webmd.com/cancer/tc/ncicdr0000062789-treatment-of-neuroepithelial-tumor-of-the-kidney">Treatment of Neuroepithelial Tumor of the Kidney</option><option value="http://www.webmd.com/cancer/tc/ncicdr0000062789-treatment-of-congenital-mesoblastic-nephroma">Treatment of Congenital Mesoblastic Nephroma</option><option value="http://www.webmd.com/cancer/tc/ncicdr0000062789-treatment-of-renal-cell-carcinoma">Treatment of Renal Cell Carcinoma</option><option value="http://www.webmd.com/cancer/tc/ncicdr0000062789-treatment-of-recurrent-wilms-tumor-and-other-childhood-kidney-tumors">Treatment of Recurrent Wilms Tumor and Other Childhood Kidney Tumors</option><option value="http://www.webmd.com/cancer/tc/wilms-tumor-and-other-childhood-kidney-tumors-treatment-pdq-treatment---health-professional-information-nci-changes-to-this-summary-11--27--2012">Changes to This Summary (11&nbsp;/&nbsp;27&nbsp;/&nbsp;2012)</option><option value="http://www.webmd.com/cancer/tc/ncicdr0000062789-about-this-pdq-summary">About This PDQ Summary</option><option value="http://www.webmd.com/cancer/tc/ncicdr0000062789-get-more-information-from-nci">Get More Information From NCI</option></select>
     <input class="submit-btn_fmt" name="submit" value="" alt="Go" type="submit" />
    </form>
   </div>
   <script type="text/javascript" language="JavaScript">
        selectNextArticle('NextTopicPulldown',s_furl.toLowerCase());
    </script>
   <div class="topicArtNav_rdr" id="TopicListCenter">
    <h4>Wilms Tumor and Other Childhood Kidney Tumors Treatment (PDQ&reg;): Treatment - Health Professional Information [NCI] Topics </h4>
    <div class="dash_fmt"></div>
    <div class="leftCol_fmt">
     <ul>
      <li><a href="http://www.webmd.com/cancer/tc/wilms-tumor-and-other-childhood-kidney-tumors-treatment-pdq-treatment---health-professional-information-nci-nci_ncicdr0000062789-nci-header" onclick="return sl(this,'','topicNav_1');" title="Nci">Nci</a></li>
      <li><a href="http://www.webmd.com/cancer/tc/wilms-tumor-treatment-health-professional-information-nci-pdq-general-information" onclick="return sl(this,'','topicNav_2');" title="General Information">General Information</a></li>
      <li><a href="http://www.webmd.com/cancer/tc/wilms-tumor-treatment-health-professional-information-nci-pdq-cellular-classification" onclick="return sl(this,'','topicNav_3');" title="Cellular Classification">Cellular Classification</a></li>
      <li><a href="http://www.webmd.com/cancer/tc/wilms-tumor-treatment-health-professional-information-nci-pdq-stage-information" onclick="return sl(this,'','topicNav_4');" title="Stage Information">Stage Information</a></li>
      <li><a href="http://www.webmd.com/cancer/tc/wilms-tumor-treatment-health-professional-information-nci-pdq-treatment-option-overview" onclick="return sl(this,'','topicNav_5');" title="Treatment Option Overview">Treatment Option Overview</a></li>
      <li><a href="http://www.webmd.com/cancer/tc/ncicdr0000062789-treatment-of-wilms-tumor" onclick="return sl(this,'','topicNav_6');" title="Treatment of Wilms Tumor">Treatment of Wilms Tumor</a></li>
      <li><a href="http://www.webmd.com/cancer/tc/ncicdr0000062789-treatment-of-clear-cell-sarcoma-of-the-kidney" onclick="return sl(this,'','topicNav_7');" title="Treatment of Clear Cell Sarcoma of the Kidney">Treatment of Clear Cell Sarcoma of the Kidney</a></li>
      <li><a href="http://www.webmd.com/cancer/tc/ncicdr0000062789-treatment-of-rhabdoid-tumor-of-the-kidney" onclick="return sl(this,'','topicNav_8');" title="Treatment of Rhabdoid Tumor of the Kidney">Treatment of Rhabdoid Tumor of the Kidney</a></li>
     </ul>
    </div>
    <div class="rightCol_fmt">
     <ul>
      <li><a href="http://www.webmd.com/cancer/tc/ncicdr0000062789-treatment-of-neuroepithelial-tumor-of-the-kidney" onclick="return sl(this,'','topicNav_9');" title="Treatment of Neuroepithelial Tumor of the Kidney">Treatment of Neuroepithelial Tumor of the Kidney</a></li>
      <li><a href="http://www.webmd.com/cancer/tc/ncicdr0000062789-treatment-of-congenital-mesoblastic-nephroma" onclick="return sl(this,'','topicNav_10');" title="Treatment of Congenital Mesoblastic Nephroma">Treatment of Congenital Mesoblastic Nephroma</a></li>
      <li><a href="http://www.webmd.com/cancer/tc/ncicdr0000062789-treatment-of-renal-cell-carcinoma" onclick="return sl(this,'','topicNav_11');" title="Treatment of Renal Cell Carcinoma">Treatment of Renal Cell Carcinoma</a></li>
      <li><a href="http://www.webmd.com/cancer/tc/ncicdr0000062789-treatment-of-recurrent-wilms-tumor-and-other-childhood-kidney-tumors" onclick="return sl(this,'','topicNav_12');" title="Treatment of Recurrent Wilms Tumor and Other Childhood Kidney Tumors">Treatment of Recurrent Wilms Tumor and Other Childhood Kidney Tumors</a></li>
      <li><a href="http://www.webmd.com/cancer/tc/wilms-tumor-and-other-childhood-kidney-tumors-treatment-pdq-treatment---health-professional-information-nci-changes-to-this-summary-11--27--2012" onclick="return sl(this,'','topicNav_13');" title="Changes to This Summary (11&nbsp;/&nbsp;27&nbsp;/&nbsp;2012)">Changes to This Summary (11&nbsp;/&nbsp;27&nbsp;/&nbsp;2012)</a></li>
      <li><a href="http://www.webmd.com/cancer/tc/ncicdr0000062789-about-this-pdq-summary" onclick="return sl(this,'','topicNav_14');" title="About This PDQ Summary">About This PDQ Summary</a></li>
      <li><a href="http://www.webmd.com/cancer/tc/ncicdr0000062789-get-more-information-from-nci" onclick="return sl(this,'','topicNav_15');" title="Get More Information From NCI">Get More Information From NCI</a></li>
     </ul>
    </div>
   </div>
   <script language="javascript" type="text/javascript">
        highlightCenter();
  </script>
   <div class="moduleSpacer_rdr"></div>
   <div id="remoteAd_rdr">
    <div class="centerAd_r1_rdr">
     <div class="centerAd_BG_fmt">
      <div class="conta" style="color:#737373; clear:both; display:none;">
       Continue reading below...
      </div>
      <div class="remoteAd_top_fmt"></div>
      <div id="remoteAd_fmt" class="remoteAd_BG_fmt">
       <div class="ad_placeholder"></div>
      </div>
      <div class="remoteAd_bottom_fmt"></div>
     </div>
    </div>
    <div class="moduleSpacer_rdr"></div>
   </div>
   <div id="triggerFlyin"></div>
   <script type="text/javascript">
	require(['fly_in/1/fly_in'], function(flyIn){
		flyIn.init('#triggerFlyin');
	});
	</script>
   <div class="moduleSpacer_rdr"></div>
   <script language="javascript1.2" type="text/javascript">
        /* Array of Partner Names */
        var partnerNames=[
        "Good Housekeeping",
        "Redbook",
        "Esquire",
        "Country Living",
        "Marie Claire",
        "Oxmoor House",
        "\"Health",
        "Southern Living",
        "Psychology Today",
        "EatingWell",
        "DrGreene.com",
        "Men's Health",
        "Women's Health",
        "Prevention",
        "eDiets",
        "Feature from \"body",
        "Runner's World",
        "Men's Fitness\" Magazine",
        "Shape\" Magazine",
        "Fit Pregnancy\" Magazine",
        "Natural Health\" Magazine",
        "\"Best Life\" Magazine"
        ]

        /* Array of names that go with files in partners node */
        var partnerScripts=[
        "goodHousekeeping",
        "redbook",
        "esquire",
        "countryLiving",
        "marieClaire",
        "cookingLight",
        "health",
        "southernLiving",
        "psychToday",
        "eatingWell",
        "drGreene",
        "mensHealth",
        "womensHealth",
        "prevention",
        "eDiets",
        "bodySoul",
        "runnersWorld",
        "mensFitness",
        "shapeMag",
        "fitPregnancy",
        "naturalHealth",
        "bestLife"
        ]

        /* Variables for whether a partner exists and which one in the array it is */
        var isThere;
        var whichOne = -1;

        /* Pulls the pub source out of the XML */
        var pubSource = 'Healthwise - NCI';

        /* Runs through the different partners and sees if one of them exists in the pub source */
        for (var i=0; i <= partnerNames.length-1; i++) {
          isThere = pubSource.search(partnerNames[i]);
          if (isThere != -1)
            {whichOne = i}
        }

        /* If it found one, makes the JS calls and also populates the correct divs with the files out of partners node */
        if (whichOne != -1) {

          document.write('<scr' + 'ipt src="http://img.webmd.com/dtmcms/live/webmd/consumer_assets/site_images/javascript/partners/' + partnerScripts[whichOne] + '.js"' + '></scr' + 'ipt>');

          var moduleCenter = "ContentPane8";
          var moduleRight = "ContentPane25";

          addLoadEvent(function() {
              document.getElementById(moduleCenter).innerHTML += writePartnerCenter();
              document.getElementById(moduleRight).innerHTML = writePartnerRight() + document.getElementById(moduleRight).innerHTML;
          })

        }

      </script>
   <script type="text/javascript">
        if (document.getElementById("headerLinks_print")) {
        setClass('headerLinks_print','headerLinks_fmt_on');
        };
      </script>
   <link rel="stylesheet" type="text/css" href="http://img.webmd.com/dtmcms/live/webmd/PageBuilder_Assets/CSS/print.css" media="print" />
   <style media="screen">
        #url_reference {display: none};
        </style>
   <style media="print">
        #url_reference { display: block; line-height: 150%; margin-bottom: 10px; }
        #logo_rdr img { visibility: visible; }
        .titleBar_rdr .titleBarMiddle_fmt { padding-top: 1.5em !important;}
        </style>
   <script type="text/javascript">
          var insert1 = document.getElementById("ContentPane2");
          var urlDiv = articleUrl();
          if (insert1) {
            insert1.appendChild(urlDiv);
            }
        </script>
  </div> 
  <div id="ContentPane6"></div> 
  <div id="ContentPane7"></div> 
  <div id="ContentPane8"></div> 
  <div id="ContentPane9"></div> 
  <div id="ContentPane10"></div> 
  <div id="ContentPane11">
   <div class="related_reading_rdr" id="rltd-p-1022"> 
    <h4>Top Picks</h4> 
    <ul> 
     <li id="x62" class="first"> <a href="http://www.webmd.com/cancer/features/15-cancer-symptoms-women-ignore" onclick="return sl(this,'','rltd-p-1022_1');">15 Cancer Symptoms Women Ignore</a> </li> 
     <li id="x63"> <a href="http://www.webmd.com/cancer/video/sleep-and-cancer" onclick="return sl(this,'','rltd-p-1022_2');">Sleep Problems and Cancer</a> </li> 
     <li id="x64"> <a href="http://www.webmd.com/cancer/features/see-cancer-specialist" onclick="return sl(this,'','rltd-p-1022_3');">Cancer: Should You See a Specialist?</a> </li> 
     <li id="x65"> <a href="http://www.webmd.com/cancer/features/8-ways-to-lower-cancer-risk" onclick="return sl(this,'','rltd-p-1022_4');">8 Ways to Lower Your Cancer Risk</a> </li> 
     <li id="x66"> <a href="http://www.webmd.com/cancer/video/chemo-nausea-side-effect" onclick="return sl(this,'','rltd-p-1022_5');">Chemotherapy Side Effects</a> </li> 
     <li id="x67" class="last"> <a href="http://www.webmd.com/melanoma-skin-cancer/slideshow-precancerous-skin-lesions-and-skin-cancer" onclick="return sl(this,'','rltd-p-1022_6');">See What Skin Cancer Looks Like</a> </li> 
    </ul> 
    <script class="oas_template" id="oas_top_picks" type="text/html">
    <a class="{type_prefix}{type}" onclick="return sl(this,'','rltd-p-1022_{link_position}');" href="{href}">{alt}{i_tag}</a>
  </script> 
    <script type="text/javascript">
				webmd.oas = window.webmd.oas || {}; webmd.oas.mapping = window.webmd.oas.mapping || {}; webmd.oas.mapping['oas_top_picks'] = ['x62','x63','x64','x65','x66','x67'];
			</script> 
   </div> 
   <script type="text/javascript"> 
				function moveMustSeeArticles() {
					/* make the swap function available internally */
					function doSwap() {	
						/* get must-see articles, remove from the DOM */
						var msa = $('#mainContentContainer_area .related_reading_rdr').clone();
						$('#mainContentContainer_area .related_reading_rdr').remove();
						
						/* get the pagination if it exists */
						var pagination = $('.attribution_rdr .pagination_fmt');
						var contextual = $('.other_context_links_rdr');
						var article = $('.article_rdr');
						
						/* certain pages use another format:
						// the top picks module is in .related_wrapper .dyn_related
						// as the second div with this class.
						// it has an id, unlike the other div */
						var dyn_related = $('.related_wrapper .dyn_related[id]');
						
						/* if dyn_related, it is handled one way */
						if(dyn_related.html()) {
							/* on last page, .related_wrapper is displayed and "Top Picks" should stay
							// on other pages, it should move down */
							if(dyn_related.parent().css('display') === 'none') {
								var dyn_related_clone = dyn_related.clone();
								dyn_related.remove();
								$(pagination).after('<div class="related_wrapper" style="display: block;" id="related_wrapper_2"></div>')
								$('#related_wrapper_2').append(dyn_related_clone);
							}
						/* if not dyn_related, it is handled   this way */
						} else {
							/* if pagination exists, insert must-see articles before the pagination,
							else insert before the next node after the contextual related links,
							else insert before the next node after the article */
							if (pagination.html()) {
								$(pagination).after(msa);
								msa.css('padding-top','30px');
							} else if (contextual.html()) {
								$(contextual).after(msa);
							} else {
								$(article).after(msa);
							}
						}
						
						/* show */
						$('#mainContentContainer_area .related_reading_rdr').show();
                        
					}
                    
                    
					
                    /* do the swap unless the function getPubType exists and returns the value 'third_party', unless it is Healthy Day content */
					if (s_publication_source = 'WebMD News from HealthDay'){
                    	doSwap();
                    } else if(typeof(getPubType) == 'function') {
						(getPubType() == 'third_party') ? null : doSwap();
					} else {
						doSwap();
					}
				}
                                if (window.$) { 
					moveMustSeeArticles();
					$('.share_rdr').hide();
					}
                    
                     $(document).ready(function() 
                     {
                    	$('.related_wrapper').css('display','block');
                        $('.dyn_related').css('padding-top','0px');  
                     });  
			</script>
  </div> 
  <div id="ContentPane12"></div> 
  <div id="ContentPane13"></div> 
  <div id="ContentPane14"></div> 
  <div id="ContentPane15"></div> 
  <div id="ContentPane16"></div> 
  <div id="ContentPane17">
   <!--Topic Directory Related Articles Module-->
   <!--
updated 09/20/10 15:17
<webmd_rendition><content><wbmd_asset object_type="wbmd_pb_module" id="091e9c5e80b888df" xmlns:xalan="http://xml.apache.org/xalan" xmlns:fn="http://www.w3.org/2005/02/xpath-functions"><webmd_module><module_settings><chronic_id>091e9c5e80692f78</chronic_id><r_object_id>091e9c5e80b888df</r_object_id><title>lln-tdrelcon</title><object_name>module_td-rltd-art_091e9c5e80692f78.xml</object_name><object_type>wbmd_pb_templatemodule</object_type><wbmd_pb_module_category></wbmd_pb_module_category><wbmd_pb_module_tier>0</wbmd_pb_module_tier><wbmd_pb_cache_duration>1440</wbmd_pb_cache_duration><r_modify_date>10/26/2012 12:56:58</r_modify_date><wbmd_pb_asset_css path="/webmd/PageBuilder_Assets/CSS/TopicDirectoryRelatedArticles/Related Articles/Standard Health Center_091e9c5e806829f6.css" object_type="wbmd_pb_css" chronic_id="091e9c5e806829f6"></wbmd_pb_asset_css><wbmd_pb_module_xsl path="/webmd/PageBuilder_Assets/XSL/TopicDirectoryRelatedArticles/Related Articles_091e9c5e806829f5.xsl" object_type="wbmd_pb_xsl" chronic_id="091e9c5e806829f5"></wbmd_pb_module_xsl><wbmd_pb_moduledataschema path="/webmd_uk/PageBuilder_Assets/schemas/module_schemas/TopicDirectoryRelatedArticles.xsd" object_type="wbmd_pb_schemas" chronic_id="091e9c5e80680965"></wbmd_pb_moduledataschema><wbmd_pb_moduledataschema path="/webmd/PageBuilder_Assets/schemas/module_schemas/TopicDirectoryRelatedArticles.xsd" object_type="wbmd_pb_schemas" chronic_id="091e9c5e80680965"></wbmd_pb_moduledataschema><wbmd_pb_owner_page_id path="/webmd/PageBuilder_Assets/scopemaps/WebMD Consumer/Templates/Cancer Health Center/template_Cancer Health Center_091e9c5e80024927.xml" object_type="wbmd_pb_template" chronic_id="091e9c5e80024927"></wbmd_pb_owner_page_id><dnn_id>0</dnn_id><class>TopicDirectoryRelatedArticles</class></module_settings><module_data><collection_categories></collection_categories></module_data></webmd_module></wbmd_asset></content><friendlyurls></friendlyurls><referenced_objects></referenced_objects><container_hierarchy></container_hierarchy><expanded_objects></expanded_objects><topic_dirs><topic_dir><name>Wilms Tumor</name><link_title>Wilms Tumor</link_title><description>Wilms tumor is a kidney cancer that usually affects children. Causes are unknown, but many cases are highly curable if the tumor has not spread. Follow the links below to find WebMD's comprehensive coverage about  Wilms tumor, symptoms, how to treat it, and much more.</description><friendly_url>http://www.webmd.com/cancer/wilms-tumor-directory</friendly_url></topic_dir><related_assets><asset id="091e9c5e800f444c"><link_title>Wilms Tumor and Other Childhood Kidney Tumors Treatment (PDQ®): Treatment - Health Professional Information [NCI]-Treatment Option Overview</link_title><friendly_url>http://www.webmd.com/cancer/tc/wilms-tumor-treatment-health-professional-information-nci-pdq-treatment-option-overview</friendly_url><thumbnail height="" width="" alt=""></thumbnail><collection_category_val>1006</collection_category_val><archive>0</archive></asset><asset id="091e9c5e800f444a"><link_title>Wilms Tumor and Other Childhood Kidney Tumors Treatment (PDQ®): Treatment - Health Professional Information [NCI]-Cellular Classification</link_title><friendly_url>http://www.webmd.com/cancer/tc/wilms-tumor-treatment-health-professional-information-nci-pdq-cellular-classification</friendly_url><thumbnail height="" width="" alt=""></thumbnail><collection_category_val>1006</collection_category_val><archive>0</archive></asset><asset id="091e9c5e800f3e0e"><link_title>Wilms Tumor and Other Childhood Kidney Tumors Treatment (PDQ®): Treatment - Patient Information [NCI]-Treatment Option Overview</link_title><friendly_url>http://www.webmd.com/cancer/tc/ncicdr0000415235-treatment-option-overview</friendly_url><thumbnail height="" width="" alt=""></thumbnail><collection_category_val>1006</collection_category_val><archive>0</archive></asset><asset id="091e9c5e800f3e11"><link_title>Wilms Tumor and Other Childhood Kidney Tumors Treatment (PDQ®): Treatment - Patient Information [NCI]-Recurrent Wilms Tumor and Other Childhood Kidney Tumors</link_title><friendly_url>http://www.webmd.com/cancer/tc/ncicdr0000415235-recurrent-wilms-tumor-and-other-childhood-kidney-tumors</friendly_url><thumbnail height="" width="" alt=""></thumbnail><collection_category_val>1006</collection_category_val><archive>0</archive></asset><asset id="091e9c5e800f3e0d"><link_title>Wilms Tumor and Other Childhood Kidney Tumors Treatment (PDQ®): Treatment - Patient Information [NCI]-Stages of Wilms Tumor and Other Childhood Kidney Tumors</link_title><friendly_url>http://www.webmd.com/cancer/tc/ncicdr0000415235-stages-of-wilms-tumor-and-other-childhood-kidney-tumors</friendly_url><thumbnail height="" width="" alt=""></thumbnail><collection_category_val>1006</collection_category_val><archive>0</archive></asset><asset id="091e9c5e80298e2f"><link_title>Wilms Tumor and Other Childhood Kidney Tumors Treatment (PDQ®): Treatment - Patient Information [NCI]-To Learn More About Wilms Tumor and Other Childhood Kidney Tumors</link_title><friendly_url>http://www.webmd.com/cancer/tc/ncicdr0000415235-to-learn-more-about-wilms-tumor-and-other-childhood-kidney-tumors</friendly_url><thumbnail height="" width="" alt=""></thumbnail><collection_category_val>1006</collection_category_val><archive>0</archive></asset><asset id="091e9c5e800f3e12"><link_title>Wilms Tumor and Other Childhood Kidney Tumors Treatment (PDQ®): Treatment - Patient Information [NCI]-Treatment Options for Wilms Tumor and Other Childhood Kidney Tumors</link_title><friendly_url>http://www.webmd.com/cancer/tc/ncicdr0000415235-treatment-options-for-wilms-tumor-and-other-childhood-kidney-tumors</friendly_url><thumbnail height="" width="" alt=""></thumbnail><collection_category_val>1006</collection_category_val><archive>0</archive></asset><asset id="091e9c5e800f444b"><link_title>Wilms Tumor and Other Childhood Kidney Tumors Treatment (PDQ®): Treatment - Health Professional Information [NCI]-Stage Information</link_title><friendly_url>http://www.webmd.com/cancer/tc/wilms-tumor-treatment-health-professional-information-nci-pdq-stage-information</friendly_url><thumbnail height="" width="" alt=""></thumbnail><collection_category_val>1006</collection_category_val><archive>0</archive></asset><asset id=""><link_title>Can antiperspirants cause kidney disease?</link_title><friendly_url>http://answers.webmd.com/answers/1198439/can-antiperspirants-cause-kidney-disease</friendly_url><thumbnail height="" width="" alt=""></thumbnail><collection_category_val>1012</collection_category_val><archive>0</archive></asset><asset id=""><link_title>How do I know if I have kidney cancer?</link_title><friendly_url>http://answers.webmd.com/answers/1194546/how-do-i-know-if-i</friendly_url><thumbnail height="" width="" alt=""></thumbnail><collection_category_val>1012</collection_category_val><archive>0</archive></asset><asset id="091e9c5e8027bb65"><link_title>Transplant Surgery Abroad Rife With Risks</link_title><friendly_url>http://www.webmd.com/news/20081016/transplant-surgery-abroad-rife-with-risks</friendly_url><thumbnail height="" width="" alt="kidney_transplants_abroad_risky.jpg">http://img.webmd.com/dtmcms/live/webmd/consumer_assets/site_images/articles/thumbnails_daily_images/2008/October08/kidney_transplants_abroad_risky.jpg</thumbnail><collection_category_val>1005</collection_category_val><archive>1</archive></asset><asset id="091e9c5e80006e63"><link_title>Inadequate Hand-Washing Found Among Health Care Workers</link_title><friendly_url>http://www.webmd.com/news/19991115/inadequate-hand-washing-found-health-care-workers</friendly_url><thumbnail height="" width="" alt=""></thumbnail><collection_category_val>1005</collection_category_val><archive>1</archive></asset><asset id="091e9c5e8000f371"><link_title>High Cholesterol Raises Kidney Risks</link_title><friendly_url>http://www.webmd.com/news/20030721/high-cholesterol-raises-kidney-risks</friendly_url><thumbnail height="" width="" alt=""></thumbnail><collection_category_val>1005</collection_category_val><archive>1</archive></asset><asset id="091e9c5e801a8038"><link_title>Kidney Disease Hospitalizations Soar</link_title><friendly_url>http://www.webmd.com/news/20080327/kidney-disease-hospitalizations-soar</friendly_url><thumbnail height="" width="" alt="More Have Kidney Disease">http://img.webmd.com/dtmcms/live/webmd/consumer_assets/site_images/articles/thumbnails_daily_images/2008/March08/more_have_kidney_disease.jpg</thumbnail><collection_category_val>1005</collection_category_val><archive>1</archive></asset><asset id="091e9c5e8051647f"><link_title>Long-Term Health Risks Low for Kidney Donors</link_title><friendly_url>http://www.webmd.com/news/20100309/low-long-term-health-risk-for-kidney-donors</friendly_url><thumbnail height="" width="" alt="survivor_of_kidney_donors.jpg">http://img.webmd.com/dtmcms/live/webmd/consumer_assets/site_images/articles/thumbnails_daily_images/2010/03_2010/survivor_of_kidney_donors.jpg</thumbnail><collection_category_val>1005</collection_category_val><archive>1</archive></asset><asset id="091e9c5e80012255"><link_title>Organ Donation &#45;&#45; New Technique Could Make Pigs Better Donors</link_title><friendly_url>http://www.webmd.com/news/20030115/pig-sperm-transfers-human-genes</friendly_url><thumbnail height="" width="" alt=""></thumbnail><collection_category_val>1005</collection_category_val><archive>1</archive></asset><asset id="091e9c5e8059f1e4"><link_title>Health Woes Common in Childhood Cancer Survivors</link_title><friendly_url>http://www.webmd.com/cancer/news/20100524/health-woes-common-in-childhood-cancer-survivors</friendly_url><thumbnail height="" width="" alt="!cancer_survivor_lifelong_health_problems.jpg">http://img.webmd.com/dtmcms/live/webmd/consumer_assets/site_images/articles/thumbnails_daily_images/2010/05_2010/!cancer_survivor_lifelong_health_problems.jpg</thumbnail><collection_category_val>1005</collection_category_val><archive>1</archive></asset><asset id="091e9c5e8000d5f7"><link_title>Less-Invasive Procedure Brings More Kidney Donations</link_title><friendly_url>http://www.webmd.com/news/20000411/less-invasive-procedure-brings-more-kidney-donations</friendly_url><thumbnail height="" width="" alt=""></thumbnail><collection_category_val>1005</collection_category_val><archive>1</archive></asset><asset id="091e9c5e8000da2d"><link_title>Another Danger for Smokers: Kidney Disease</link_title><friendly_url>http://www.webmd.com/smoking-cessation/news/20001016/another-danger-for-smokers-kidney-disease</friendly_url><thumbnail height="" width="" alt=""></thumbnail><collection_category_val>1005</collection_category_val><archive>1</archive></asset><asset id="091e9c5e8000bbee"><link_title>Regular Use of Pain Medicines Doesn't Damage Kidneys</link_title><friendly_url>http://www.webmd.com/news/20010717/regular-use-of-pain-medicines-doesnt-damage-kidneys</friendly_url><thumbnail height="" width="" alt=""></thumbnail><collection_category_val>1005</collection_category_val><archive>1</archive></asset><asset id="091e9c5e8000e7a3"><link_title>Regular Use of Pain Medicines Doesn't Damage Kidneys</link_title><friendly_url>http://www.webmd.com/news/20010717/regular-use-of-pain-medicines-doesnt-damage-kidneys-news</friendly_url><thumbnail height="" width="" alt=""></thumbnail><collection_category_val>1005</collection_category_val><archive>1</archive></asset><asset id="091e9c5e80007552"><link_title>IgA Nephropathy</link_title><friendly_url>http://www.webmd.com/a-to-z-guides/iga-nephropathy-shc</friendly_url><thumbnail height="" width="" alt=""></thumbnail><collection_category_val>1006</collection_category_val><archive>0</archive></asset><asset id="091e9c5e800071fb"><link_title>Analgesic Nephropathy</link_title><friendly_url>http://www.webmd.com/a-to-z-guides/analgesic-nephropathy</friendly_url><thumbnail height="" width="" alt=""></thumbnail><collection_category_val>1006</collection_category_val><archive>0</archive></asset><asset id="091e9c5e8000ee34"><link_title>Mice Grow Human Kidneys</link_title><friendly_url>http://www.webmd.com/cancer/news/20021227/mice-grow-human-kidneys</friendly_url><thumbnail height="" width="" alt=""></thumbnail><collection_category_val>1005</collection_category_val><archive>1</archive></asset><asset id="091e9c5e80128a49"><link_title>Study Links Bread, Kidney Cancer Risk</link_title><friendly_url>http://www.webmd.com/cancer/news/20061020/study-links-bread-kidney-cancer-risk</friendly_url><thumbnail height="" width="" alt=""></thumbnail><collection_category_val>1005</collection_category_val><archive>1</archive></asset><asset id="091e9c5e801cc807"><link_title>Acrylamide in Diet: Cancer Risk?</link_title><friendly_url>http://www.webmd.com/cancer/news/20080508/acrylamide-in-diet-cancer-risk</friendly_url><thumbnail height="" width="" alt="Acrylamides and Kidney Cancer">http://img.webmd.com/dtmcms/live/webmd/consumer_assets/site_images/articles/thumbnails_daily_images/2008/May08/acrylamides_and_kidney_cancer.jpg</thumbnail><collection_category_val>1005</collection_category_val><archive>1</archive></asset><asset id="091e9c5e80761900"><link_title>Kidney Cancer on the Rise</link_title><friendly_url>http://www.webmd.com/cancer/news/20110222/kidney-cancer-on-the-rise</friendly_url><thumbnail height="" width="" alt="kidneys">http://img.webmd.com/dtmcms/live/webmd/consumer_assets/site_images/articles/thumbnails_daily_images/2011/02_2011/69x75_renal_cancer_rise.jpg</thumbnail><collection_category_val>1005</collection_category_val><archive>1</archive></asset><asset id="091e9c5e80129c70"><link_title>Social Challenges for Kids Who Survive Cancer</link_title><friendly_url>http://www.webmd.com/children/news/20050912/social-challenges-kids-survive-cancer</friendly_url><thumbnail height="" width="" alt=""></thumbnail><collection_category_val>1005</collection_category_val><archive>1</archive></asset><asset id="091e9c5e800067f5"><link_title>Effects of Childhood Cancer Can Linger Long After Disease Is Gone</link_title><friendly_url>http://www.webmd.com/cancer/non-hodgkins-lymphoma/news/20070101/childhood-cancer-effects-linger</friendly_url><thumbnail height="" width="" alt=""></thumbnail><collection_category_val>1005</collection_category_val><archive>1</archive></asset><asset id="091e9c5e8030b1cb"><link_title>FDA OKs New Kidney Cancer Drug</link_title><friendly_url>http://www.webmd.com/cancer/news/20090402/fda-oks-new-kidney-cancer-drug</friendly_url><thumbnail height="75" width="69" alt="kidney_cancer_drug.jpg">http://img.webmd.com/dtmcms/live/webmd/consumer_assets/site_images/articles/thumbnails_daily_images/2009/April_2009/kidney_cancer_drug.jpg</thumbnail><collection_category_val>1005</collection_category_val><archive>1</archive></asset></related_assets></topic_dirs></webmd_rendition>
--> 
   <div class="related_wrapper">
    <div class="dyn_related">
     <h4 class="JS-TEST3">Further Reading:</h4>
     <ul>
      <li><a href="http://answers.webmd.com/answers/1198439/can-antiperspirants-cause-kidney-disease" onclick="return sl(this,'','lln-tdrelcon_1');">Can antiperspirants cause kidney disease?</a></li>
      <li><a href="http://www.webmd.com/cancer/tc/wilms-tumor-treatment-health-professional-information-nci-pdq-treatment-option-overview" onclick="return sl(this,'','lln-tdrelcon_2');">Wilms Tumor and Other Childhood Kidney Tumors Treatment (PDQ&reg;): Treatment - Health Professional Information [NCI]-Treatment Option Overview</a></li>
      <li><a href="http://www.webmd.com/cancer/tc/wilms-tumor-treatment-health-professional-information-nci-pdq-cellular-classification" onclick="return sl(this,'','lln-tdrelcon_3');">Wilms Tumor and Other Childhood Kidney Tumors Treatment (PDQ&reg;): Treatment - Health Professional Information [NCI]-Cellular Classification</a></li>
      <li><a href="http://www.webmd.com/cancer/tc/ncicdr0000415235-treatment-option-overview" onclick="return sl(this,'','lln-tdrelcon_4');">Wilms Tumor and Other Childhood Kidney Tumors Treatment (PDQ&reg;): Treatment - Patient Information [NCI]-Treatment Option Overview</a></li>
      <li><a href="http://www.webmd.com/cancer/tc/ncicdr0000415235-recurrent-wilms-tumor-and-other-childhood-kidney-tumors" onclick="return sl(this,'','lln-tdrelcon_5');">Wilms Tumor and Other Childhood Kidney Tumors Treatment (PDQ&reg;): Treatment - Patient Information [NCI]-Recurrent Wilms Tumor and Other Childhood Kidney Tumors</a></li>
      <li><a href="http://www.webmd.com/cancer/tc/ncicdr0000415235-stages-of-wilms-tumor-and-other-childhood-kidney-tumors" onclick="return sl(this,'','lln-tdrelcon_6');">Wilms Tumor and Other Childhood Kidney Tumors Treatment (PDQ&reg;): Treatment - Patient Information [NCI]-Stages of Wilms Tumor and Other Childhood Kidney Tumors</a></li>
      <li><a href="http://www.webmd.com/cancer/tc/ncicdr0000415235-to-learn-more-about-wilms-tumor-and-other-childhood-kidney-tumors" onclick="return sl(this,'','lln-tdrelcon_7');">Wilms Tumor and Other Childhood Kidney Tumors Treatment (PDQ&reg;): Treatment - Patient Information [NCI]-To Learn More About Wilms Tumor and Other Childhood Kidney Tumors</a></li>
      <li class="last_link"><a href="http://www.webmd.com/cancer/wilms-tumor-directory" onclick="return sl(this,'','lln-tdrelcon_all');">See All Wilms Tumor Topics</a></li>
     </ul>
    </div>
   </div>
   <script type="text/javascript"> 
                    	$('.related_wrapper').css('display','block');  
			</script>
  </div> 
  <div id="ContentPane18">
   <div class="centerAd_r1_rdr"> 
    <div id="centerAd_fmt" class="centerAd_BG_fmt"> 
     <iframe title="Center ICM" width="494" height="1" marginwidth="0" marginheight="0" style="margin:0;" frameborder="0" scrolling="no" src="http://as.webmd.com/html.ng/transactionID=1935586914&amp;tile=1915703674&amp;tug=&amp;pug=__&amp;site=2&amp;affiliate=20&amp;hcent=&amp;scent=848&amp;pos=5000&amp;xpg=2729&amp;sec=&amp;au1=&amp;au2=&amp;uri=%2fcancer%2ftc%2fwilms-tumor-treatment-health-professional-information-nci-pdq-general-information&amp;artid=091e9c5e800f4449&amp;inst=0&amp;leaf=1146&amp;cc=16&amp;tmg=1&amp;bc=_age1_&amp;mcent=&amp;micro="> &lt;script language=&quot;JavaScript1.2&quot; type=&quot;text/javascript&quot; charset=&quot;ISO-8859-1&quot; src=&quot;http://as.webmd.com/js.ng/Params.richmedia=yes&amp;amp;transactionID=1935586914&amp;amp;tile=1915703674&amp;amp;tug=&amp;amp;pug=__&amp;amp;site=2&amp;amp;affiliate=20&amp;amp;hcent=&amp;amp;scent=848&amp;amp;pos=5000&amp;amp;xpg=2729&amp;amp;sec=&amp;amp;au1=&amp;amp;au2=&amp;amp;uri=%2fcancer%2ftc%2fwilms-tumor-treatment-health-professional-information-nci-pdq-general-information&amp;amp;artid=091e9c5e800f4449&amp;amp;inst=0&amp;amp;leaf=1146&amp;amp;cc=16&amp;amp;tmg=1&amp;amp;bc=_age1_&amp;amp;mcent=&amp;amp;micro=&quot;&gt; &lt;/script&gt; </iframe> 
     <script type="text/javascript">
					$("#centerAd_Iframe_c1").load(function() { $("#centerAd_top_fmt").addClass("loaded"); $(".centerAd_top_fmt").addClass("loaded"); });
				</script> 
    </div> 
   </div> 
   <div class="moduleSpacer_rdr"> 
   </div> 
   <script language="JavaScript1.2" type="text/javascript">
			var priTopId = "2729";
			var secTopId = "";
		</script>
   <div class="centerAd_r1_rdr"> 
    <div id="centerAd_fmt" class="centerAd_BG_fmt"> 
     <iframe title="Center ICM" width="494" height="1" marginwidth="0" marginheight="0" style="margin:0;" frameborder="0" scrolling="no" src="http://as.webmd.com/html.ng/transactionID=1935586914&amp;tile=1915703674&amp;tug=&amp;pug=__&amp;site=2&amp;affiliate=20&amp;hcent=&amp;scent=848&amp;pos=5001&amp;xpg=2729&amp;sec=&amp;au1=&amp;au2=&amp;uri=%2fcancer%2ftc%2fwilms-tumor-treatment-health-professional-information-nci-pdq-general-information&amp;artid=091e9c5e800f4449&amp;inst=0&amp;leaf=1146&amp;cc=16&amp;tmg=1&amp;bc=_age1_&amp;mcent=&amp;micro="> &lt;script language=&quot;JavaScript1.2&quot; type=&quot;text/javascript&quot; charset=&quot;ISO-8859-1&quot; src=&quot;http://as.webmd.com/js.ng/Params.richmedia=yes&amp;amp;transactionID=1935586914&amp;amp;tile=1915703674&amp;amp;tug=&amp;amp;pug=__&amp;amp;site=2&amp;amp;affiliate=20&amp;amp;hcent=&amp;amp;scent=848&amp;amp;pos=5001&amp;amp;xpg=2729&amp;amp;sec=&amp;amp;au1=&amp;amp;au2=&amp;amp;uri=%2fcancer%2ftc%2fwilms-tumor-treatment-health-professional-information-nci-pdq-general-information&amp;amp;artid=091e9c5e800f4449&amp;amp;inst=0&amp;amp;leaf=1146&amp;amp;cc=16&amp;amp;tmg=1&amp;amp;bc=_age1_&amp;amp;mcent=&amp;amp;micro=&quot;&gt; &lt;/script&gt; </iframe> 
     <script type="text/javascript">
					$("#centerAd_Iframe_c1").load(function() { $("#centerAd_top_fmt").addClass("loaded"); $(".centerAd_top_fmt").addClass("loaded"); });
				</script> 
    </div> 
   </div> 
   <div class="moduleSpacer_rdr"> 
   </div> 
   <script language="JavaScript1.2" type="text/javascript">
			var priTopId = "2729";
			var secTopId = "";
		</script>
  </div> 
  <div id="ContentPane19"></div> 
  <div id="ContentPane20"></div> 
 </div> 
</div>